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Preface 
The Centers for Medicare and Medicaid Services (CMS), through a subcontract with Yale New 
Haven Health Services Corporation, Center for Outcomes Research and Evaluation (YNHHSC/CORE), 
is supporting a committee appointed by the Committee of Presidents of Statistical Societies (COPSS) 
to address statistical issues identiﬁed by the CMS and stakeholders about CMS’s approach to mod­
eling hospital quality based on outcomes. In the spring of 2011, with the direct support of YN­
HHSC/CORE, COPSS formed a committee comprised of one member from each of its constituent 
societies, a chair, and a staﬀ member from the American Statistical Association, and held a prelim­
inary meeting in April. In June, YNHHSC/CORE executed a subcontract with COPSS under its 
CMS contract to support the development of a White Paper on statistical modeling. Speciﬁcally, 
YNHHSC/CORE contracted with COPSS to “provide guidance on statistical approaches . . . when 
estimating performance metrics,” and “consider and discuss concerns commonly raised by stake­
holders (hospitals, consumer, and insurers) about the use of “hierarchical generalized linear models 
in proﬁling hospital quality. The committee convened in June and August of 2011, and exchanged 
a wide variety of materials. To ensure the committee’s independence, YNHHSC/CORE did not 
comment on the white paper ﬁndings, and CMS pre-cleared COPSS’ publication of an academic 
manuscript based on the White Paper. 
The committee thanks COPSS and especially its chair, Xihong Lin of the Harvard School of Public 
Health; and staﬀ of the American Statistical Association, especially Steve Pierson and Keith Crank, 
for their eﬀorts in establishing the committee and coordinating its work. We thank Darcey Cobbs-
Lomax and Elizabeth Drye of the Yale Center for Outcomes Research and Evaluation (CORE), 
Yale New Haven Hospital who issued the contract on behalf of CMS. 
COPSS developed a special formal review process for this report with the goals of ensuring that it 
is objective and addresses the CMS charge. Consequently, this report was reviewed in draft form 
by professionals with a broad range of perspectives and expertise. Xihong Lin coordinated the 
review. We thank her and the following individuals for donating their time and expertise: Adal­
steinn Brown, University of Toronto; Jim Burgess, Boston University; Justin Dimick, University of 
Michigan; Frank Harrell, Vanderbilt University; Jack Kalbﬂeisch, University of Michigan; Catarina 
Kiefe, University of Massachusetts; Niek Klazinga, University of Amsterdam; Neil Prime, Care 
Quality Commission, UK; Susan Paddock, The RAND Cooperation; Patrick Romano, University 
of California at Davis; David Spiegelhalter, University of Cambridge; Robert Wolfe, University of 
Michigan; Alan Zaslavsky, Harvard Medical School; and three anonymous reviewers. 
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The Committee of Presidents of Statistical Societies (COPSS) 
Charter member societies of the Committee of Presidents of Statistical Societies (COPSS) are: 
the American Statistical Association, the Eastern North American Region of the International 
Biometric Society, the Institute of Mathematical Statistics, the Statistical Society of Canada, and 
the Western North American Region of the International Biometric Society. COPSS leadership 
consists of the Chair, Secretary/Treasurer, Presidents, Past Presidents, and Presidents-Elect of the 
charter member societies. 
The preamble to the COPSS charter states, 
“Whereas the various societies have distinct characteristics they also have some 
common interests and concerns that can beneﬁt from coordinated eﬀort. The purpose 
of the Committee of Presidents of Statistical Societies (COPSS) is to work on shared 
problems, to improve intersociety communication, and to oﬀer distinguished awards. 
Other activities designed to promote common interests among the member societies 
may be undertaken from time to time.” 
See, (http://nisla05.niss.org/copss/) for additional information. 
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Executive Summary 
The Centers for Medicare and Medicaid Services (CMS) charged the committee to: 
“Provide guidance on statistical approaches for accounting for clustering and variable sample 
sizes across hospitals when estimating hospital-speciﬁc performance metrics (e.g., mortality 
or readmission rates).” 
and to 
“Consider and discuss concerns commonly raised by stakeholders (hospitals, consumers, and 
insurers) about the use of HGLMs [Hierarchical Generalized Linear Models] in public reporting 
of hospital quality.” 
The committee addresses this charge and related issues with the goal of enhancing the validity, 
credibility, and clarity of the CMS evaluations of hospital performance. In doing so the committee 
began by interpreting CMS’s broad goal to be: 
Provide hospital-speciﬁc performance metrics for an array of procedures that incorpo­
rate the best possible information for each hospital as to how well it performs with its 
patients in comparison to the outcomes that would be expected if the same patients 
were to receive care that matched the national norm. 
Given CMS’s congressional mandate, these metrics clearly involve point estimates of performance, 
in the form of a standardized mortality rate, and assessment of the uncertainty associated with 
such estimates. 
The committee reviews the hierarchical modeling approach to performance measures based on the 
concept of a standardized mortality ratio, and contrasts the current CMS approach with other 
approaches proposed in the literature. The report describes the assumptions underlying diﬀerent 
methods and the extent to which there is empirical support for them. The report sets this discussion 
in the broader context of statistical methods for a variety of other purposes, especially in the context 
of large sparse data sets, and includes suggestions for improving upon the current CMS method. 
The following Commentary and Recommendations duplicate section 11 of the full report. 
Commentary on principal criticisms of the current CMS approach 
The committee has addressed the criticisms received by the CMS in response to the use of hierar­
chical logistic regression modeling in measure development as follows: 
Criticism 1: The approach fails to reveal provider performance variation: The hierarchical modeling 
shrinkage eﬀect reduces reported variation of hospital performance and renders the information not 
useful for consumers. 
Committee view: The CMS seeks to report on systematic diﬀerences in patient outcome due 
to hospital quality, after removing variability in observed outcomes that is due to diﬀerences 
in case mix and stabilizing highly variable estimates. Even after risk adjustment for case-
mix diﬀerences, inherent randomness causes directly estimated hospital eﬀects and relative 
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rates (that is, O/E ratios where the observed rate (O) is divided by its national model 
based expected rate (E)) for some hospitals to vary more than the systematic eﬀects that 
are to be identiﬁed. This is especially true for hospitals with extremely low volumes, whose 
ratios provide little information about their underlying relative rates due to having very 
wide conﬁdence intervals. Large reductions in reported variation are appropriate for hospital 
performance measures where the true systematic diﬀerences across all hospitals are small. 
The committee identiﬁes as a top priority evaluating the option of expanding the model to 
include shrinkage targets that depend on hospital attributes. 
Criticism 2: The approach masks performance of small hospitals: It is pointless to include small 
(low volume) hospitals in the calculations based on hierarchical modeling because they would get a 
rate close to the national mean. The hierarchical modeling methodology neutralizes small hospital 
performance. 
Committee view: Data from small hospitals provide considerable information on associations 
between patient case mix and the outcome for parameter estimation in the hierarchical model; 
therefore, their data should be included in model building. The standard errors of hospital-
speciﬁc estimates for low volume hospitals are typically large. Stabilization requires that 
these highly variable estimates are moved towards a model-based target to a greater degree 
than less variable estimates, resulting in more shrinkage for low volume hospital estimates. 
The overarching goal is to produce estimates that better reﬂect true, underlying hospital 
eﬀects. As stated in the response to criticism 1, the committee identiﬁes as a top priority 
evaluating the option of expanding the model to include shrinkage targets that depend on 
hospital attributes. 
Criticism 3: The approach is based on complicated concepts and is diﬃcult to communicate and 
explain to the public and to the providers. Stakeholders are familiar with the numerator and the 
denominator (O/E) and the output of logistic regression modeling, but the approach adopted by 
CMS replaces the “O” with a shrinkage estimate (referred to as “predicted” in CMS documents), 
and the concept is diﬃcult to convey. In addition the concept of a hospital-speciﬁc eﬀect is not 
comprehensible to most of the stakeholders. 
Committee view: Some concepts and computations are more complicated than for the stan­
dard logistic regression approach, but the additional complexity allows for respecting the 
hierarchical structure of the data and stabilizing estimates, thereby reducing regression to 
the mean eﬀects and bouncing around of provider-speciﬁc estimates. Furthermore, a ﬁxed-
eﬀects, logistic regression model also produces hospital-speciﬁc eﬀects. There is a continuum 
between the single-intercept, random eﬀects model and the ﬁxed-eﬀects model with a directly 
estimated intercept for each hospital, with the middle ground being occupied by a mixed 
eﬀects model that includes hospital-level covariates. Therefore, barriers to comprehension of 
the concept are shared by all approaches. This report clariﬁes the principal building blocks 
of the approaches. The committee calls for improved communication on goals, methods, and 
interpretations. 
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Criticism 4: The evaluation of the National Quality Forum (NQF) steering committees on use 
of hierarchical modeling has been inconsistent, contingent on the point of view of the panelists. 
Therefore, it shows a lacks of consensus among statisticians and health service researchers in using 
hierarchical modeling for risk adjustment of outcome measures. 
Committee view: The committee notes that to make progress on this issue, and possibly come 
to consensus, the debate must be evidence-based starting with a clear articulation of goals and 
ending with eﬀective evaluation of the properties of candidate approaches. The committee 
recommends use of hierarchical models as an eﬀective method to account for clustering of 
admissions within providers, to support valid and eﬀective risk adjustment, and to produce 
stabilized estimates, although it recognizes that other approaches can accomplish these goals. 
This report clariﬁes goals and why hierarchical models are a valid approach, and focuses 
discussion on potential enhancements of the current CMS method. 
The committee’s investigation has led to the following conclusions and recommendations: 
1. Use of Hierarchical Generalized Linear Models 
The committee concludes that Hierarchical Generalized Linear Logistic Modeling is an 
eﬀective analytic approach that accounts for the structure of the data used in CMS 
mortality and readmission hospital metrics. The approach accommodates modeling of 
the association between outcomes and patient-level, pre-admission characteristics; with 
appropriate inclusion of hospital-level attributes, it can adjust the patient-outcome rela­
tion for potential confounding by hospital to the degree that the necessary information 
is available; and supports stabilizing hospital-speciﬁc performance estimates by shrink­
ing direct estimates towards an appropriate target. The amount of shrinkage can be 
controlled to the extent that these controls accord with CMS’ primary goal (see Recom­
mendations 3, 4, and 5 below). 
2. Incorporation of procedure-speciﬁc volume 
Other recommendations encourage serious consideration of including hospital-level (not 
procedure-speciﬁc) attributes in the national-level, case mix adjustment model and in 
setting shrinkage targets for stabilizing estimated hospital eﬀects. The committee cau­
tions that the issues related to use of procedure-speciﬁc volume are complex. Volume 
has a combined role as both an exogenous attribute that may be an independent predic­
tor of quality (e.g., practice makes perfect) and an endogenous attribute that is in the 
causal pathway of the outcome. Furthermore, “low procedure-speciﬁc volume” may be a 
marker for an inadequate risk adjustment that disadvantages hospitals with low-volume 
procedures. 
Though evaluation of including procedure-speciﬁc volume is important, the committee 
recommends that higher priority be given to use of other hospital-level attributes in 
modeling case-mix and in producing shrinkage targets. However, regarding volume, use 
3


of procedure-speciﬁc volume from time periods prior to those used in an assessment is 
likely not problematic and should be explored for its ability to contribute to better-
tailored shrinkage targets. 
3. Case-mix adjustment 
(a) Patient-level attributes 
i. Consider whether the current set of patient-level attributes should be augmented, 
for example by including race or other demographics. 
ii. Evaluate broadening modeling approaches to include additional interaction terms 
among patient-level attributes. 
iii. Evaluate further broadening patient-level models through use of splines, classiﬁ­
cation and regression trees, random forests, and boosting (see section 8) to see if 
relative to current approaches they improve case mix adjustments by producing 
predictions with lower mean squared error, or improve other performance measures 
such as those in Efron (1978). 
It will be important to explore the extent to which alternative modeling strategies im­
prove case-mix adjustments by producing predictions with lower mean squared error (i.e., 
predictions that are closer to the true structural relation), or improve other statistical 
attributes. 
(b) Hospital-level attributes 
The committee recommends that the CMS explore how best to include hospital 
attributes for two distinct purposes: 1) when developing the national-level risk 
model to reduce potential confounding induced by correlation between hospital and 
patient-level attributes; and 2) when calculating the shrinkage targets used to stabi­
lize SMRs. Incorporating them is an accepted approach in other facility assessment 
settings. It is very important to note that hospital-level attributes should not set 
the comparator for a hospital’s performance; indeed, the denominator of the SMR 
should depend only on a validly estimated relation between patient-level attributes 
and outcome. However, there may be confounding of this relationship with certain 
hospital characteristics, and methods to reduce this confounding should be explored. 
To reduce confounding and stabilize hospital-speciﬁc estimates, the committee pro­
poses in appendix F.1 a Bayesian hierarchical model that adjusts for hospital-level 
attributes when developing the risk model, but constrains risk predictions to be for 
a “typical hospital” so that hospital-level attributes play no other role in producing 
the expected value for a hospital. The model also allows for hospital-attribute­
speciﬁc shrinkage targets to stabilize estimated SMRs. 
The committee cautions that although statistical models are available to accomplish 
these goals, decisions as to what attributes to include and how to include them must 
4

be carefully considered. For example, covariate interactions may be needed (e.g., 
between hospital size and rural/urban status). Coding for candidate attributes needs 
to be evaluated. For example, should size be retained as a continuous attribute or 
be categorized? If categorized, how should the number of categories, and their cutoﬀ 
values, be determined? 
4. Stabilizing estimated hospital eﬀects 
(a) Including hospital-level attributes in determining the shrinkage target when stabiliz­
ing estimated hospital eﬀects is standard practice in other facility assessment settings. 
The committee recommends that the CMS give serious consideration to including such 
variables in setting shrinkage targets. To reduce potential confounding, covariate main 
eﬀects and possibly interactions should be considered (e.g., shrinkage targets could be 
diﬀerent for each of small-rural, large-rural, small-urban, and large-urban hospitals). As 
noted in recommendation (3b), various coding choices for candidate attributes should 
be explored and evaluated. 
(b) Evaluate the policy and statistical implications of replacing the single Gaussian prior dis­
tribution for the hospital-speciﬁc random eﬀects by a more ﬂexible class of distributions 
(see appendix H). 
(c) Consider supplementing posterior mean estimates with histogram estimates. These re­
port the distribution of the SMRs with appropriate location, spread and shape (see 
appendix I). 
5. Readmission rates 
Evaluate, modify and implement the method for assessing readmission rates proposed 
in section 7. 
6. Model assessment 
Evaluate augmented approaches to model assessment (see section 8). 
7. Enhance reporting 
CMS should enhance its reporting to further emphasize uncertainty and improve inter­
pretation. The committee suggests enhancements such as: using exceedance probabili­
ties; juxtaposing a histogram of the patient-speciﬁc risk estimates for each hospital with 
a histogram of the national distribution, or of the distribution for a relevant group of 
comparator hospitals to clarify important between-hospital diﬀerences (see section 9). 
8. Promulgate standards of conduct and communication 
(a) Develop and communicate standards of practice for data collection, analysis and report­
ing for adoption by those conducting hospital comparisons. 
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(b) Implement a transparent, continuous process of examining the consequences of the many, 
often independent, analytic choices made to ensure that what is done is as straightfor­
ward and accessible as it can be, consistent with meeting well-articulated standards for 
a “well-performing” quality reporting system. 
9. Transfer technology to other CMS evaluations 
The statistical and policy issues considered in this report operate in the broad array 
of CMS performance measures and are relevant regardless of disease condition or pro­
cess measure. Therefore, CMS should broaden its evaluations to domains other than 
assessment of thirty-day, post-discharge mortality and readmission rates. However, the 
speciﬁc choices may depend on context. For example, dialysis centers may all report a 
suﬃcient number of events so that a ﬁxed-eﬀects rather than a random-eﬀects approach 
can be used in developing the national-level model and the SMRs. 
6


1 Introduction 
The Centers for Medicare and Medicaid Services (CMS) has a congressional mandate to evaluate 
hospital performance using risk-standardized mortality rates, other process-of-care outcomes, and 
risk-standardized readmission rates. These legislative requirements and associated challenges are 
not unique to the CMS. As Spiegelhalter et al. (2012) note, increasing availability of clinical outcome 
data and increased concern for accountability, “has led to an increased focus on statistical methods 
in healthcare regulation” for the three principal functions of “rating organizations, deciding whom 
to inspect and continuous surveillance for arising problems.” 
The CMS, through a subcontract with Yale New Haven Health Services Corporation, Center for 
Outcomes Research and Evaluation (YNHHSC/CORE), supported a committee appointed by the 
Committee of Presidents of Statistical Societies (COPSS) to address statistical issues identiﬁed 
by the CMS and stakeholders about the CMS approach to modeling hospital quality based on 
outcomes. In the spring of 2011, with the direct support of YNHHSC/CORE, COPSS formed a 
committee comprised of one member from each of its constituent societies, a chair, and a staﬀ 
member from the American Statistical Association, and held a preliminary meeting in April. In 
June, YNHHSC/CORE executed a subcontract with COPSS under its CMS contract to support the 
development of a White Paper on statistical modeling. Speciﬁcally, YNHHSC/CORE contracted 
with COPSS to “provide guidance on statistical approaches . . . when estimating performance met­
rics,”and “consider and discuss concerns commonly raised by stakeholders (hospitals, consumer, and 
insurers) about the use of hierarchical generalized linear models in proﬁling hospital quality.” The 
committee convened twice, in June and August of 2011, and exchanged a wide variety of materials 
electronically. To ensure the committee’s independence, YNHHSC/CORE did not comment on the 
report’s ﬁndings, and CMS pre-cleared COPSS’ publication of an academic manuscript based on 
the White Paper. 
The ability to estimate hospital performance accurately based on patient outcome data relies upon 
several factors. Most basically, the outcome needs reﬂect something that is directly aﬀected by the 
quality of hospital care. Beyond this, however, there are a number of important data and analytic 
considerations: (1) Data must be available and used to adjust for diﬀerences in patient health 
at admission across diﬀerent hospitals (case-mix diﬀerences). These adjustments are required to 
ensure that variations in reported performance apply to hospitals’ contributions to their patients’ 
outcomes rather than to the intrinsic diﬃculty of the patients they treat. Of course, performance 
of the adjustments depends on the type and quality of available data, and in the CMS context data 
have been validated against medical chart information. (2) In distinct contrast to the previous 
point, reported performance should not adjust away diﬀerences related to the quality of the hospital. 
For example, if “presence of a special cardiac care unit” is systematically associated with better 
survival following a heart attack, a hospital’s reported performance should capture the beneﬁt 
provided by that unit and as a consequence such hospital-level attributes should not inﬂuence the 
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risk adjustment. (3) The reported performance measure should be little aﬀected by the variability 
associated with rates based on the small numbers of cases seen at some hospitals. 
These desired features of a performance measure require the development of a statistical model 
to adjust for facility diﬀerences in case-mix (a risk-adjustment model), and the use of an analytic 
method that reports sensible rates for all facilities, including those with few observed outcomes. 
In this report, the committee discusses issues in producing a credible risk-adjustment model, but 
focuses primarily on methods for partitioning the remaining variation into that (a) associated 
with variation within hospitals for a homogeneous group of patients, and (b) produced by between­
hospital variation. Successful partitioning will avoid, to the extent possible, misclassifying hospitals. 
But even the best methods cannot completely prevent high-quality hospitals from being incorrectly 
characterized as having relatively poor outcomes or failing to identify the shortfalls of some lower-
quality providers, especially if they are low-volume, i.e., with few patients for the procedure in 
question. Indeed, all statistical procedures have such operating characteristics and these must be 
evaluated in the context of a speciﬁc application. 
This report addresses both broad and more technical statistical issues associated with mortality and 
readmission hospital measures. The content principally responds to the extended debrieﬁng pro­
vided by Lein Han, Ph.D. regarding CMS’s concerns (see appendix D). Subsequent sections identify 
key goals and relevant approaches, outline current approaches, identify possible modiﬁcations, and 
recommend study of the potentially most important, high leverage of these. 
The committee concludes that the current CMS approach is eﬀective, but that even within the 
current framework, reﬁnements that have the potential to improve performance and credibility of 
the assessments should be considered. Model enhancements include use of more ﬂexible models for 
case mix adjustment; broadening the class of distributions from the current Gaussian family used 
in the hierarchical, random eﬀects model; evaluation of the eﬀectiveness of current outlier detection 
methods; and consideration of producing an ensemble of hospital-speciﬁc Standardized Mortality 
Ratios that accurately estimates the true, underlying distribution of ratios via a histogram. In 
addition, within the current framework, the CMS should consider augmenting reports to improve 
communication and to provide additional cautions regarding interpreting results. 
The decision on incorporating hospital characteristics, especially hospital volume, is crucial and 
relates to both the risk adjustment and stabilization components of the hospital evaluation process. 
All stakeholders agree that risk adjustments should not reﬂect hospital characteristics, but their 
use in reducing confounding of the case-mix/risk relation has been advocated. More contentious is 
their use in the component of a model that stabilizes estimates. Statistical models are available for 
each of these operations, and the committee presents options. The ability to develop and implement 
such models has never been in question, but the advisability of broadening the adjustment model 
from an overall shrinkage target to hospital-attribute-speciﬁc determined targets has generated 
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considerable debate. The committee provides information on the conceptual and technical issues 
associated with such models, and identiﬁes studies and policy choices that should precede a decision 
on this issue. 
2 Issues in Statistical Modeling of SMRs 
The CMS needs to quantify the following mandate: 
“How does this hospital’s mortality for a particular procedure compare to that predicted 
at the national level for the kinds of patients seen for that procedure or condition at 
this hospital?” 
There is an explicit comparison here between the hospital at issue and a counterfactual hospital 
at the national level, because it is very unlikely that there is another hospital with exactly the 
same case-mix. Indeed, the CMS warns that one should not compare hospitals. In this regard, it 
is unfortunate that the CMS website reporting quality ratings is titled “hospital compare.” 
Krumholz et al. (2006) discuss several factors that should be considered when assessing hospital 
quality. These relate to diﬀerences in the chronic and clinical acuity of patients at hospital pre­
sentation, the numbers of patients treated at a hospital, the frequency of the outcome studied, the 
extent to which the outcome reﬂects a hospital quality signal, and the form of the performance 
metric used to assess hospital quality. Additional issues in developing, implementing, and reporting 
results from hospital proﬁling and readmission evaluation include: attaining consensus on goals, 
respecting the observational nature of available data and its hierarchical structure; producing valid 
and eﬀective case mix adjustments; reporting credible point estimates for the hospital eﬀects associ­
ated with patient outcomes including readmission rates; smoothing to deal with unstable estimates; 
and addressing the challenges in validly interpreting and eﬀectively communicating results. 
The performance measure reported by the CMS is the stabilized, indirectly risk-standardized, 
hospital-speciﬁc death rate (see appendix E.1). The basic estimate is, 
Observed # of deaths 
Standardized death rate = × (the national-level death rate) 
Expected # of deaths 
= SMR× (the national-level death rate). 
Thus 
Observed # of deaths 
SMR = . (1) 
Expected # of deaths 
The denominator of equation (1) is the result from applying a model that adjusts/standardizes 
for an ensemble of patient-level, pre-admission risk factors, rather than only demographic factors 
such as age and gender as is typical in epidemiological applications. The statistical issues arising in 
the estimation of the standardized death rate and the SMR in the CMS assessments are identical 
because the latter is simply the hospital-speciﬁc value divided by the expected number of deaths 
computed from the national risk model. Due to the calibration provided by the SMR (SMR = 
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1.0 always implies typical performance relative to the national standard for the types of patients 
treated at the hospital), the committee focuses on it throughout this report. 
2.1 Calibration to a hospital-attribute speciﬁc standard 
This report focuses on proﬁles relative to the overall national standard because that is how the 
committee interprets the CMS’s mandate. Indeed, all discussion in this report related to including 
hospital-level attributes addresses issues in how to stabilize basic estimates; not on changing the 
standard to which hospitals are compared. However, standardization to a comparator (a denom­
inator) other than the overall, national standard is easily available by stratiﬁcation on hospital 
types with separate analyses in each stratum or by generalizing the current case-mix adjustment 
models to include hospital attributes. For example, using a stratiﬁed approach, one might develop 
one SMR for community hospitals and another one for teaching hospitals. In each case an SMR 
= 1.0 would indicate typical performance for a given case-mix and the speciﬁc hospital type, and 
would not necessarily indicate compatibility with an overall, national standard. 
2.2 Proﬁling versus decision-making 
Two, distinct goals can be considered when evaluating mortality outcomes: 
Proﬁling: “How does this hospital’s mortality for a particular procedure or condition compare 
to that predicted at the national level for the kinds of patients seen for that procedure or 
condition at this hospital?” 
Decision-making: “Given my medical status and needs, to which hospital should I go for a 
particular procedure or treatment of my condition?” 
Though the decision-making goal is important, it is not the topic the CMS tasked the committee 
to address. 
The proﬁling goal: One can address the proﬁling goal by developing a valid national-level model 
for the probability of death as a function of patient-speciﬁc attributes, using this national-level 
model to compute the expected number of deaths for a hospital’s mix of patient-speciﬁc attributes 
(its case-mix), and comparing the actual number of deaths to this expected value, producing the 
Standardized Mortality Ratio (SMR). Proﬁling entails aggregation over a mix of patients. Thus, 
while a hospital with a low SMR (indicating lower than expected mortality) might be a good choice 
for a speciﬁc patient, it may be that the hospital performs relatively poorly for that kind of patient. 
Similarly, a hospital with a relatively high SMR, indicating higher than expected mortality, might 
perform well for that patient even though its average performance over a mix of patients is relatively 
poor. In addition, if the case-mix adjustment is inadequate, the playing ﬁeld for hospitals will not 
be level, especially for procedures with a complex case-mix. Some hospitals treat only relatively 
easy cases while others specialize in diﬃcult ones and any analytical approach needs to take this 
diﬀerential into account when computing expected deaths. 
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The decision-making goal: These characteristics of the SMR help diﬀerentiate the proﬁling goal from 
the decision-making goal, which is best addressed by developing a rich model for the probability of 
death as a function of patient-speciﬁc characteristics plus all relevant hospital characteristics. An 
eﬀective model would include main eﬀects and interactions among patient-level attributes, among 
hospital-level attributes and between these two sets of attributes. For example, if “presence of a 
special cardiac care unit” is associated with survival, then it would be appropriate to include it in 
such a model. 
To clarify the diﬀerence between proﬁling and decision-making, consider two facilities treating 
patients having a particular medical condition. Hospital A sees primarily low-risk patients for whom 
the expected death rate is 6%, while hospital B is a tertiary referral hospital with most patients 
being extremely sick, and that collectively have an expected death rate of 16%. Suppose that 
both facilities perform as expected; that is, the observed death rates are 6% and 16%, respectively, 
and that the case-mix adjustment is correct. Both facilities will be proﬁled with an SMR = 1.0. 
These calculations send the right message for many purposes, but are not designed to address the 
decision-making goal because they were not designed to provide information about whether hospital 
A might be a better choice than hospital B for a particular kind of patient. 
3 Components of a Proﬁling Approach 
Developing an estimator of hospital-speciﬁc performance based on outcome measures, for example 
in computing the SMR (see equation 1), requires several strategic decisions. They relate to the 
types of covariates included in the model (patient and hospital); the statistical model for the 
outcome (probability of the outcome and the relation between the probability of the outcome and 
the covariates); and calculation of the hospital performance measure. In this context, the committee 
considers issues associated with case mix adjustment, low information and the observational study 
context. Many of these issues translate directly to assessment of readmission rates and we consider 
issues of particular pertinence to readmission rates in section 7. 
The following components are essential building blocks for a valid approach to estimating hospital-
speciﬁc SMRs. 
• 	 Respect the probability process and hierarchical structure of the data. 
• 	 Develop an eﬀective case-mix, risk adjustment so that to the extent possible with available 
data, the expected number of events produced from the national-level model is free of patient­
level inﬂuences, producing as level a playing ﬁeld as possible. 
• 	 Stabilize the basic SMR to improve estimation and prediction performance. 
The principal issues and approaches associated with each component are outlined below. 
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3.1 Respect the probability process and hierarchical structure of the data 
Because patient-speciﬁc outcomes are binary (e.g., a death indicator), a Bernoulli model operating 
at the patient level is appropriate. Risk adjustment and stabilization should respect this model and 
thus logistic regression is a suitable approach for including the eﬀects of patient-level attributes. 
Alternatives to the logistic include the probit and other links. With ﬂexible modeling of covariate 
inﬂuences, each would produce a valid risk adjustment and there is no reason to replace the logistic 
by another link function. Furthermore, because some hospitals for some conditions have either a 
small number of patients or a small number of events, it is important to use the core, Bernoulli 
model to represent stochastic uncertainty rather than an approach that would be valid only for 
large hospital-speciﬁc sample sizes. 
In this setting, patients are nested within hospitals so that their outcomes may be correlated due to 
receiving care from providers in the same hospital. While an individual may contribute more than 
one admission at more than one hospital for the same procedure or condition (of course, for the 
death outcome there is only one event), CMS does not use linkage at this level and thus patients 
are eﬀectively nested within hospital. A hierarchical model is most appropriate for respecting this 
nesting structure, and section 4.3 contains additional information on this topic. 
3.2 Develop an eﬀective case-mix, risk adjustment 
The evaluation process must be based on an eﬀective case-mix, risk adjustment so that to the extent 
possible with available data, the expected number of events produced from the national-level model 
is free of patient-level inﬂuences, producing as level a playing ﬁeld as possible. Though one might 
wish to have additional information of patient attributes and clinical severity, even with currently 
available data the CMS should evaluate whether a more ﬂexible case-mix adjustment model will 
improve performance. Most important is evaluating when one should augment the model to reduce 
potential confounding by hospital of the patient-attribute/risk relation. The committee discusses 
approaches in section 4. 
Patient attributes are of the three types, measured and accounted for, measurable but not ac­
counted for, and attributes that are diﬃcult or impossible to measure. All agree that risk adjust­
ments should include pre-admission medical conditions, but whether or not to include demographic 
attributes is a policy decision, one with clear consequences. For example, if outcomes for minority 
group patients are generally less good than for the majority group and race is included in the risk 
adjustment model, then hospitals that treat a relatively large number of minority patients will get 
credit because the expected number of events will be larger than if race were not in the model. 
Therefore, including race would give a hospital credit for treating this category of patients. Of 
course, the reverse is true; omitting race from the risk adjustment model may be seen as penalizing 
such hospitals. Variation in outcomes that is due to patient attributes that are omitted from the 
adjustment (or adjustments that use them inappropriately) is absorbed by the hospital-speciﬁc 
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eﬀects that are used to compare performance and omissions of this type may not suﬃciently “level 
the playing ﬁeld” when comparing hospital performance. 
3.3 Stabilize the basic SMR 
Most, but not all, stakeholders agree that the method used to estimate the SMR requires some form 
of stabilization, at least for public reporting (administrative reporting and quality assurance and 
quality control reporting may not need it). When the number of events used in a direct estimate 
of an SMR is small, the estimate is unstable, with a relatively large standard error or coeﬃcient of 
variation (the standard error divided by the estimate), and its statistical performance is poor. In 
the following, “directly estimated” quantities refer to estimates based on hospital-speciﬁc, observed 
mortality events divided by the expected number of events obtained from a logistic regression 
model. 
The hierarchical, Bayesian formalism provides a valid and eﬀective approach to this stabilization 
goal, though other formulations are possible. The approach posits a prior distribution for hospital­
speciﬁc, random eﬀects and a “data model” (the core logistic regression) that is a function of these 
eﬀects and patient-level pre-admission attributes. The Bayesian formalism adopted by CMS pro­
duces the posterior distribution of the hospital-speciﬁc random eﬀects and uses this distribution to 
produce the reported SMR estimates, uncertainties and other descriptors. The approach stabilizes 
estimates because directly estimated SMRs (see equation 1) are shrunken toward the prior mean 
by an amount that depends on the standard error of the estimate. Relatively unstable estimates 
are adjusted to a greater extent than are relatively stable estimates. 
The use of the Bayesian formalism is by no means a panacea. All models require careful speciﬁ­
cation and rigorous evaluation. Model performance depends on correct speciﬁcation of the “data 
model” (e.g., the core logistic regression). Validity of the hierarchical approach also depends on the 
form of the distribution for the hospital-speciﬁc random eﬀects and the summary used to do the 
stabilization. The current CMS approach uses a Gaussian distribution for hospital eﬀects measured 
in the logistic scale, and the committee identiﬁes generalizations of this approach in appendix H. 
These somewhat technical issues are important, but essentially not controversial. The key issue of 
contention relates to whether the shrinkage target should depend on hospital-level attributes, with 
volume being the variable of greatest concern (see section 6). 
3.4 The current CMS approach 
The current CMS approach (see appendix E.1 and equation 3 for details) provides a valid and 
eﬀective approach that respects the data structure. It incorporates the primary components of 
variance at the hospital and patient levels. It implements risk adjustment for case-mix and sta­
bilization of the estimated SMR by shrinkage toward the national mean value using all patients 
from all hospitals (the national mean produces SMR = 1.0). The method’s basic construct however 
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does not directly accommodate allowing hospital-level attributes to determine shrinkage targets for 
stabilizing estimated SMRs. 
The committee concludes that the form of the current model, while eﬀective, potentially re­
quires augmentation to reduce confounding of the patient-attribute/outcome relation in developing 
national-level expected events. Also, to a degree, the form of the current model gets in the way 
of constructive debate on inclusion of hospital-level attributes in the stabilization step. Indeed, its 
seamless integration of case-mix adjustment and stabilization (a major virtue) tends to obscure 
their essentially separate roles. Clarity in this regard will by no means end the debate, but it can 
focus the debate on the correct issues. Therefore, in appendix F the committee presents two mod­
eling approaches that permit shrinkage targets that depend on hospital attributes while preserving 
the national-level referent. 
3.5 Fixed-eﬀects and random eﬀects models 
An alternative approach uses ﬁxed eﬀects (FE) models to proﬁle facilities; this approach is currently 
being used by CMS in their Dialysis Facility Reports. See, 
http://www.dialysisreports.org/pdf/esrd/public/SMRdocumentation.pdf

The hospital-speciﬁc intercepts are assumed to be ﬁxed parameters to be estimated individually 
rather than random parameters (eﬀects) that are assumed to be sampled from a probability distri­
bution (the prior). The magnitude of the estimated variance of the prior captures the unexplained, 
between-hospital variation. One of the major distinctions between random eﬀects (RE) and ﬁxed 
eﬀects (FE) models is the degree of attention to the structure of the correlations between the ob­
served and unobserved variables, correlation that can confound the patient-risk relation. In the 
basic RE model with an intercept-only probability distribution, there is no explicit attention to the 
potential correlations; in eﬀect the unobserved variables are assumed to be uncorrelated with the 
observed variables. In a FE model, saturated at hospital level (there is an intercept for each hospi­
tal) there are no such assumptions, so the model provides complete adjustment for these potential 
correlations. 
However, the committee emphasizes that there is a continuum between the basic, RE model and 
the saturated FE model. By augmenting the probability model used in the RE approach to include 
hospital attributes, the model occupies the middle ground between basic RE and full FE. Including 
these attributes “explains” some of the between-hospital variation that was unexplained in the 
basic model and the estimated variance of the prior is reduced. Including additional hospital-level 
attributes or interaction terms until the model degrees of freedom equal the number of hospitals 
results in the FE model. Because there is no between-hospital variation left to explain, the estimated 
variance of the prior is zero. 
Therefore, there is a continuum of approaches to account for correlations and adjust for potential 
confounding. One can go “all the way” with the FE approach, or go “part-way” by building a RE 
model that includes adjustment for hospital-level attributes, but does not use up all hospital-level 
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degrees of freedom. If all hospitals had suﬃcient, stand-alone data, then, subject to the form of the 
model being correct, the FE approach will ensure successful adjustment for potential confounding. 
However, if there are small numbers of patients or events in some hospitals, the FE approach can 
be biased and in any case produces higher variability. The intercept-only, RE model is consistent 
but only under the assumption of no correlation of the random intercepts with patient case mix. 
The more general, hierarchical random eﬀects (RE) model with appropriate augmentation by a 
hospital-level regression component produces estimates with the smaller MSE by trading oﬀ some 
bias for lower variance relative to the FE approach. The bias can be controlled by including 
suﬃcient hospital-level covariates and thereby producing very low correlation between the residual 
hospital-level variance components and patient-level case-mix. 
Wolfe & Kalbﬂeish (unpublished) have compared the properties of FE and the basic RE model 
for the purpose of proﬁling facilities under various conditions. When there is correlation between 
patient risk factors and hospital characteristics, such as when sicker patients are admitted system­
atically to either better- or worse-performing facilities, then basic RE estimates are biased, have 
larger MSE, and have less ability to detect exceptional facilities. Although RE have lower MSE on 
average, they showed that MSE is larger for centers with exceptional performance, in other words, 
those whose performance can be distinguished from the national mean. FE methods have substan­
tially higher power to detect outlying facilities than do RE models. When there is unmeasured 
confounding between patient risk factors and the hospital intercepts, the basic RE model does not 
provide accurate case mix adjustment. 
The Wolfe & Kalbﬂeish research shows that one needs to move beyond the basic, RE model. 
However, the committee notes that FE approach produces larger standard errors than RE estimates, 
leading to wider conﬁdence intervals. RE models allow for some residual correlation, possibly some 
residual confounding , but reduce variability. Striking an eﬀective variance/bias trade-oﬀ is a central 
tenet of all statistical modeling, and the committee recommends that the CMS augment its current 
model to include hospital-level attributes with the goal of producing a variance/bias trade-oﬀ that 
generates case-mix adjustments with very good predictive performance. 
3.6 Possible modeling approaches and the low information context 
One might conceptualize the modeling task in several diﬀerent ways, for example, through ag­
gregated models at the hospital level. The primary problem with this approach is the inability to 
control for patient- level risk factors. Patient level models make intuitive sense because they permit 
optimal control for patient-level confounding and allow for inferences to the outcomes of individual 
patients, since this is the level at which doctors make decisions and where the outcomes of those 
decisions occur. 
Hospital assessments of the sort that lie at the core of the CMS mandate occur in a relatively low 
information context. For both mortality and readmission, statistical information depends directly 
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on the number of events more than on the number of patients. Even hospitals with a large caseload 
may have few deaths or readmissions. Of course, statistical information is generally smallest for 
low-volume hospitals. Due to the large number of patient attributes and values for them, however, 
even at the national level some form of smoothing/stabilization is needed to support case-mix 
adjustments. Smoothing and stabilization are needed for both the numerator and denominator, 
when producing hospital-level, estimated SMRs or readmission rates. In eﬀect, stabilization is 
accomplished by replacing the observed number of events by a stabilized value, often described as 
“borrowing strength” across hospitals. 
The patient-level modeling strategy becomes somewhat more complex when determining which 
hospital-level characteristics to include in the model. How should one deal with the volume of 
speciﬁc procedures, hospital location (e.g., urban vs. rural, or Southeast vs. Northeast), hospital 
ownership and management (some hospitals are part of hospital systems which aﬀects who goes 
where for speciﬁc procedures), academic teaching status, number of beds and case-mix, whether 
procedures are elective or emergency-based, etc.? The committee notes that the myriad possible 
combinations of hospital characteristics prompts the need to confront data sparseness, including the 
need for smoothing/stabilization in both the numerator and denominator of the SMR in expression 
expression (1). Section 5 discusses these issues in greater depth. 
3.7 Possible data limitations 
The information CMS uses to risk-adjust comes from billing claims that characterize the diagnoses 
observed or procedures performed during the entire hospital admission and generally fail to ade­
quately characterize patient severity. While diagnoses present on admission (POA) are available, 
POA reporting accuracy varies by hospital characteristics (Goldman et al., 2011). Furthermore, for 
both medical and surgical admissions, although there is a code to indicate if it is emergent (versus 
elective) these codes may not be suﬃciently reliable to support computing separate SMRs for each 
type of admission. As another example, many aspects of decision-making associated with the ﬂow 
of patients to speciﬁc hospitals (e.g., associated with health insurance or doctors’ practices) simply 
are not recorded. The committee notes that the CMS mortality and readmission models based on 
billing data have been validated against medical records data. 
Hospital evaluations, whether those done by CMS or by external researchers, use observational data. 
Except in a relatively small number of true experiments, no one randomizes patients to hospitals 
for care; patients or their physicians choose a hospital. Choice depends on medical condition. 
For example, acute MI patients are taken to the nearest hospital, but elective surgery patients 
select a hospital based on various factors, such as surgical volume, physician recommendation, or 
word of mouth. Case mix can vary widely among hospitals. For example, coronary artery bypass 
graft (CABG) surgery is generally performed in large medical centers whereas community hospitals 
generally treat less complicated conditions and perform less complicated procedures. Even among 
hospitals performing CABG, some may specialize in treating the most complex and risky patients, 
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and others, the most routine cases. Because CMS compares hospitals relative to their own case 
mix, comparing SMRs between hospitals can be an “apples/oranges” exercise, and considerable 
caution is needed. Indeed, the CMS SMRs are produced to assess a speciﬁc hospital relative to a 
counterfactual population, and between-hospital comparisons are not valid unless there is a near 
match to the distribution of patient-speciﬁc risks. 
There may well be hospital diﬀerences in coding practice and documentation. For example, for a 
similar set of patients, diabetes may be more frequently noted in some hospitals. More generally, 
hospitals may engage in up-coding and the induced diﬀerences in case mix will favor some hospitals. 
Hospitals diﬀer in coding practices, for example with teaching hospitals documenting more than 
community hospitals (Iezzoni, 1997, 2003). Also, hospitals that engage in sophisticated up-coding 
can make their patients look sicker than the same patients would at a “typical” hospital, causing 
their case-mix-adjusted performance to look better than it otherwise would. 
3.8 Endogenous and exogenous hospital attributes 
The hierarchical logistic model that is the focus of this report is largely a descriptive model, but it is 
also imbued with a causal interpretation. Indeed, adjusting for risk has a causal interpretation. One 
could develop a more formal causal framework, usually associated with econometric simultaneous 
equations models, in which some variables are exogenous (the causes of eﬀects) and also endogenous 
(the eﬀects of causes). An interesting and perhaps important question is whether the hierarchical 
logistic model for outcomes can be viewed as a reduced form equation for such a simultaneous 
system and the consequences thereof regarding inclusion of hospital-level attributes. As discussed 
in section 6, there are implications of such causal thinking in the context of the hierarchical models 
employed by the CMS. 
4 Case-Mix Adjustment 
In developing a case-mix adjustment, CMS needs to establish a standard for what outcome is 
expected for a hospital’s patients, strictly as a function of the patients’ characteristics upon 
arrival (POA), but in a modeling framework this reduces potential confounding of the patient­
attribute/risk relation by hospital. Nothing that is “on the causal pathway” that happens after 
patients arrive at the hospital should be used to establish the “denominator” for that comparison. 
The committee provides the following discussion to highlight the strategic and tactical issues in 
adjustment and stabilization. The discussion is not intended to incorporate the full details of a 
valid approach. See appendix E for the speciﬁcs of the current CMS approach and appendix F for 
enhancements. 
Diﬀerences in hospital case-mix is one of the most widely-studied topics in the ﬁeld of health services 
research (Iezzoni, 2003). For the purposes of assessing hospital quality, risk factors generally meet 
two criteria for inclusion in performance models. First, they must characterize the patient’s health 
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 at admission. This requirement ensures that information that reﬂects how patients are handled post-
admission does not become confounded with or masked by hospital quality, the primary quantity of 
interest. For example, while cardiogenic shock may be highly predictive of mortality when measured 
after admission, the occurrence of shock may be a consequence of poor hospital care coordination. 
Inclusion of this covariate would give a hospital a “pass” for such patients. Second, patient-level and 
hospital-level characteristics require careful justiﬁcation for inclusion. For example, there is debate 
surrounding the inclusion of socio-demographic characteristics in hospital quality assessments, with 
some arguing that their inclusion may mask disparities and inequities in quality of care (Blumberg, 
1987; Iezzoni, 2003; Krumholz et al., 2006). 
For each medical or surgical condition, and for each admission in the database, the CMS data 
consist of a 30 day, post-discharge death indicator, a list of disease conditions and other patient 
attributes (such as age and sex), and the admitting hospital with its attributes. Patient outcomes 
are attributed to a hospital and variation in these outcomes can be attributed to diﬀerences in 
patient case-mix, random variation in outcomes amongst patients with the same characteristics 
treated in the same hospital, and hospital-level variation that remains after accounting for these 
patient-level factors. Case mix adjustment attempts to account for the patient-level factors, using 
the remaining hospital-level variation to compare hospital performance related to, for example, 
practice patterns and hospital resource availability. 
While hospital attributes must not be used to “tune” a risk adjustment to a hospital type, if hospital 
eﬀects are correlated with case mix factors (which is inevitably the case) the estimated case mix 
coeﬃcients will be biased and the national-level risk adjustment may not accurately consolidate 
the “rolled-up” patient-speciﬁc risks. Therefore, the case-mix risk adjustment model should be 
structured to reduce confounding by these correlation eﬀects. As outlined in, 
http://www.dialysisreports.org/pdf/esrd/public/SMRdocumentation.pdf
adjustment to reduce confounding is an accepted approach in other facility assessment settings 
and the committee recommends that serious consideration be given to such adjustments in the 
CMS context. However, when the number of patients or events is small, the saturated, ﬁxed-eﬀects 
approach cannot be used. In appendix F.1 the committee proposes a Bayesian hierarchical model 
that accomplishes the adjustment. The approach builds a model for hospital-level attributes when 
developing the risk model, but risk predictions are for a “typical” hospital and so these attributes 
do not otherwise play a role in producing the expected value for a hospital. 
The foregoing discussion highlights that inclusion or exclusion of an adjusting variable and its role 
in a model all inﬂuence the question being asked, for example the reference to which a hospital’s 
performance is compared. Candidate factors divide into three categories: 
1. Pre-admission, patient-level health attributes (i.e., case-mix): All stakeholders agree that 
using information from this category is not only appropriate, but necessary. To produce 
a fair assessment, predictions must account for patient-level, upon-admission characteristics 
that associate with outcome. The committee notes that even here several issues must be 
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considered, for example whether to include a patient’s race in the model. These and other 
such decisions are primarily ones of CMS policy and not of statistical practice. 
2. Post-admission patient attributes including events that coincide with or might be the result 
of care (e.g., in-hospital infections or patient length-of-stay): All stakeholders agree that 
including this category of information is inappropriate. Adjustment should not be made for 
post-admission events, because they are on the pathway to the outcome and adjusting for 
them would reduce the magnitude of the hospital eﬀects. 
3. Pre- or at-admission, hospital attributes (i.e., presence of cardiac catheterization laborato­
ries): There is disagreement on whether to include information from this category. For 
example, should hospital location, number of beds, condition volume, etc. be included in the 
model used to stabilize estimated hospital eﬀects? 
4.1 Inclusion of hospital-level attributes in the risk model 
It is clearly the case that hospital-level attributes from category (3) such as volume for diﬀerent 
procedures, location (urban, rural), ownership and management (for-proﬁt vs not for proﬁt), mission 
(teaching, community) status should not be used when computing expected deaths when “rolling 
up” the patient-speciﬁc probabilities in the national model that is used to produce the denominator 
for an SMR. Doing so would set a hospital attribute speciﬁc standard and an SMR = 1.0 would 
indicate that the hospital has performance that is typical for hospitals with the same case mix and 
the same hospital-level attributes. For example, urban hospitals would be compared to urban, rural 
to rural, and the SMRs would not quantify performance of rural hospitals relative to urban. While 
such comparisons might be of interest for some purposes, they would defeat the primary purpose of 
national-level proﬁling of enabling stakeholders to compare all hospitals to the national standard. 
There remain two other potential roles for category (3) attributes in national proﬁling: 
1. Reduce confounding by hospital in the patient-level risk model. Appendix F.1 reports on a 
model to accomplish this goal. 
2. Enrich the model for estimating hospital eﬀects beyond use of the current, intercept-only, 
hierarchical logistic regression model that stabilizes hospital eﬀects (and thereby estimated 
SMRs) by shrinkage to a single target. Section 5.2 provides additional discussion of this issue. 
4.2 The national-level model 
The SMR measures the ratio of what has been observed to what is expected in a particular hospital 
for the same patient case mix using a national-level model. To estimate this ratio, a model for the 
national level probability of death as a function of patient-level attributes is needed. To obtain 
the expected number of deaths for a speciﬁc hospital, a probability of death (or readmission) 
is computed for each of its admissions and these are summed. In developing the national model, 
because the patient-speciﬁc outcomes of death or readmission are binary, logistic regression treating 
the probability of death as a linear logistic function of variables has become the preferred approach 
in developing a case mix model from national data, both for CMS and for most other health services 
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researchers. Successful case-mix adjustment depends on building an eﬀective regression model for 
the patient-level attributes in the context of hospital-level variation. The full armamentarium of 
statistical modeling is available to accomplish this task. 
Hierarchical versions of logistic regression are a natural component of such models, because patient 
admissions are clustered within hospitals. In building the national-level model, the hierarchical 
structure of the data should be accommodated to the degree possible, and the model for the prob­
ability of death must be adjusted for relevant patient-level information, but not for hospital-level 
attributes. The standard logistic regression should include a suﬃciently rich model for the inﬂu­
ence of at-admission, patient attributes and to accommodate the clustering. To deal with possible 
confounding, hospital-speciﬁc intercepts are necessary. Standard choices for these intercepts are 
either ﬁxed (there is a separate, explicit intercept for each hospital, often called “dummy” or indi­
cator variables) or random (the hospital-speciﬁc intercepts are modeled as a random sample from 
a probability distribution). 
As discussed in section 3.5, the ﬁxed-eﬀects approach does provide input to a national-level, risk 
adjustment model based on the association of patient-attributes with the probability of death. 
However, by saturating the hospital-level model, it cannot incorporate the stochastic eﬀects of 
clustering. Therefore, the committee recommends use of the hierarchical, mixed-eﬀects approach 
for the national-level model of mortality outcomes (i.e., replacing the hospital-speciﬁc, ﬁxed eﬀects 
by an assumption that these eﬀects are random variables drawn from a distribution of such eﬀects). 
Importantly, the model must also adjust for hospital-level attributes to reduce potential confounding 
of the patient attribute-risk relation. Such models allow for both between- and within-hospital 
variation, but do not require a` priori that they exist. The estimated variance of the distribution 
considered to generate hospital-speciﬁc eﬀects measures the extent to which they exist above and 
beyond that associated with the hospital-level attributes included as covariates. Such a components 
of variance perspective is shared by a number of diﬀerent families of statistical models and leads 
naturally to a multi-level hierarchical model perspective rather than a standard logistic regression. 
4.3 Stabilization via hierarchical models 
The broad CMS goal is to judge a hospital’s performance based on what happens to the patients 
it actually admits with the aim of determining the hospital’s inﬂuence on outcome. Therefore, 
proﬁling models should adjust for important patient risk factors and incorporate the clustering of 
patients within the responsibility of the hospital. Hierarchical regression models, including hierar­
chical generalized linear models, respect this data structure and have other beneﬁts. They explicitly 
quantify both intra-hospital (patient-level) and inter-hospital-level variation. The estimated hos­
pital eﬀects (like hospital “signatures”) quantify the case mix adjusted residual eﬀects of hospital 
quality on patient outcomes, measured as deviations from the national mean. Variance component 
modeling induces within-provider correlation (an intra-class correlation, ICC) in that the outcomes 
of patients within the same hospital tend to be more similar than if the same patients were treated 
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in diﬀerent hospitals. It is possible that there are no hospital quality diﬀerences, that is the chance 
that a patient experiences an event after being treated is the same regardless of the hospital. In 
this case the inter- hospital variation would be zero as would the ICC, and all hospital eﬀects would 
be zero, implying no diﬀerence from the national mean. 
4.4 Stabilization via hierarchical modeling 
Stabilizing estimates is a fundamental statistical practice, in all cases employing some form of bor­
rowing strength or information. Regression models and local averaging (e.g., LOESS Cleveland and 
Devlin, 1988) are statistical mainstays of the statistical toolkit for this purpose, as are more com­
plex methods involving splines (Wang, 2011), wavelets (Morris and Carroll, 2006), and functional 
data analysis (Crainiceanu et al., 2011). Hierarchical models with shrinkage towards a regression 
surface (Carlin and Louis, 2009; Gelman et al., 2004) provide a model-based way to produce es­
timates that are close to the inferential target (producing a relatively small mean squared error) 
by stabilizing variance while retaining suﬃcient alignment with the target. Standard regression 
approaches stabilize by using the model-based predictions and the estimates; that is the direct esti­
mates (for example, the data points) are moved all the way to the regression surface. Hierarchical 
ˆmodels stabilize by moving direct estimates (in our context the β0i in equation 2 of appendix E.1) 
part-way towards the regression surface, thereby retaining some of the hospital-speciﬁc signal. 
Hierarchical models produce standard errors that incorporate the components of variation within 
and between hospitals. They also provide a framework for stabilizing estimated hospital-speciﬁc 
eﬀects by shrinkage towards a central value. Stabilization dampens the regression to the mean 
eﬀect, the phenomenon wherein hospitals found to be at the extremes in one year subsequently 
become less extreme, thereby stabilizing a sequence of assessments. This form of stabilization also 
reduces the inﬂuence of chance in the observed variation among providers. Theory and practice 
have shown that hierarchical models, carefully applied, produce estimates and predictions with 
excellent operating properties, obtained by trading-oﬀ prediction variance and bias to produce 
lower expected squared deviation (referred to as mean squared error) from the true, underlying 
relation. They have proved to be successful in a wide variety of application settings, e.g., see 
Bishop et al. (1975); Carlin and Louis (2009); Gelman et al. (2004); Normand and Shahian (2007). 
Fienberg (2011) and the associated discussion provide an excellent review of the role of Bayesian 
hierarchical models in the policy arena. The committee provides the following small sample of 
examples. 
Teacher evaluations: Teacher-level performance is measured on the basis of student performance 
on standardized achievement tests (Camilli et al., 2001; Lockwood et al., 2002; Whoriskey, 2011). 
As is the case with patients, students are clustered within classrooms and vary in their scholastic 
abilities. As is the case with hospitals, classroom and school sizes range from small to large. 
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Employment discrimination (stopping short): In legal proceedings focused on employment dis­
crimination, expert witnesses using regression models are typically required to leave out employer-
controlled variables such as rank or title that are potentially tainted and thus would mask the direct 
measure of discrimination as captured by a regression coeﬃcient for sex or race, e.g., see Dempster 
(1988); Greiner (2008). 
Census adjustment (shrinkage and controversy): In the debates over census adjustment in the 
1980s, Ericksen and Kadane (1985) proposed a regression based adjustment model that smoothed 
sample based adjustments using socio-economic and other variables to get small area adjustments 
where there was little or no direct data on adjustment. Freedman and Navidi (1986) countered that 
it was inappropriate to smooth data across state boundaries to produce adjustments that could be 
used to reallocate congressional seats among the states. 
Small area estimates of income and poverty (shrinkage and little controversy): Eﬀective estimation 
in small area requires stabilization of area-speciﬁc estimates while maintaining suﬃcient geographic 
focus. For example, Citro and Kalton (2000) report on the use of hierarchical models to produce 
estimates of income and poverty in small geographic areas. These estimates are used to allocate 
billions of dollars in school aid funds and to implement many other federal programs. 
Automobile insurance rate making (shrinkage to balance the books): In the automobile insurance 
industry, there is a long, successful history of using hierarchical models to improve the predictive 
performance of estimated accident rates. Data are cross-tabulated into a large number of categories 
formed for example by age, gender, marital status, and rating region. Direct estimates are quite 
noisy and shrinkage improves performance. See Tomberlin (1988) for an informative example. 
Healthcare regulation: rating, screening and surveillance (developments continue): Spiegelhalter 
et al. (2012) provide a variety of examples of goals and approaches used or being considered in the 
United Kingdom. 
5 Inferences in a Low-Information Context 
This section provides additional details on case-mix adjustment followed by consideration of issues 
associated with stabilizing directly estimated SMRs. 
5.1 Dealing with low information in case-mix adjustment 
All stakeholders agree that some form of stabilization is needed to produce case mix adjustments 
based on a large number of pre- or at-admission patient characteristics. The cross-tabulation 
approach, using for example the approximately 28 characteristics along with a binary indicator of 
death within 30 days of discharge, virtually always produces a small number of patients per cell. 
Indeed, if all 28 characteristics were binary, cross-classiﬁcation would result in 229 ≈ 1013 cells. 
Dealing with this decreasing direct information as the number of cross-classiﬁcation cells increases is 
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a long-standing statistical problem that can be addressed by overlapping but identiﬁable approaches 
including statistical modeling, direct smoothing, and aggregating. For example, in the 1960s in the 
context of the National Halothane Study, Bunker et al. (1969) (see also Mosteller, 2010) applied 
a variety of approaches to very sparse count data to predict mortality associated with the use of 
diﬀerent anesthetics in a large number of hospitals for diﬀerent types of procedures and with widely 
varying levels of risk. The halothane committee analyzing these data attempted to use direct and 
indirect standardization, various forms of data smoothing including log-linear and logistic models 
as well as early versions of hierarchical models. The hierarchical logistic regression models used by 
the CMS have directly evolved from this work and the class of approaches continues to expand (see 
section 8). 
5.2 Dealing with low information in stabilizing estimated SMRs 
The most politically and technically challenging aspect of statistical modeling in the CMS context 
is how to smooth or stabilize estimates when some, or even many, hospitals treat far too few cases 
of a particular kind for their data to provide stand-alone information as to their quality. This issue 
is intertwined with what to report and how to report it. For example, in a hospital where only 2 
people were admitted with a heart attack, their observed 30-day mortality can only be 0%, 50% 
or 100%. However, the national mortality rate for heart attack admissions is about 16% and any 
individual hospital’s true rate is extremely unlikely to lie outside the range from 5 to 25%, so it 
would be a mistake to report any facility’s rate as 0% or 50% based on these data. But, CMS 
must report a value for that hospital nonetheless, and the uncertainty associated with its directly 
estimated observed rate will be much greater than for a hospital with a much larger patient volume. 
The SMR, computed as the stabilized hospital-speciﬁc number of events divided by the national-
level model predicted number of events, is the object of inference. Disagreement and contention fo­
cus on the approach to stabilizing the numerator of this ratio, not the denominator. All stakeholders 
agree that neither volume nor any other hospital-level attribute should inﬂuence the national-level 
model predicted events. However a case can be made for the number of beds and other hospital-
level attributes to play a role in stabilizing the numerator. The current CMS approach stabilizes 
estimated SMRs via a hierarchical, random eﬀects logistic regression model that shrinks directly 
estimated hospital eﬀects towards an overall mean. Other methods are available, but methods that 
do not stabilize/smooth in some fashion will be less stable and very likely less accurate. 
If a large amount of information were available for all hospitals and all basic SMR estimates 
were very stable, there would be no need for additional stabilization and these estimates could be 
reported along with what would be very narrow conﬁdence intervals. However, it is common that 
many hospitals have few deaths and some hospitals have a small number of patients for a speciﬁc 
condition and so estimated SMRs are highly unstable. Though reporting SMR estimates along 
with appropriate conﬁdence intervals will communicate this uncertainty, stabilization can be used 
to reduce variability while retaining suﬃcient year-speciﬁc, hospital focus, and generally improving 
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performance. Combining input data over several years is one approach (the CMS uses the three 
most recent years), but considerable estimation uncertainty remains and pooling over additional 
years reduces the sensitivity in identifying changes over time. Therefore, a model-based approach 
is needed. 
Stabilizing through a form of shrinkage that considers all hospitals simultaneously, low and high 
volume, has the eﬀect of producing estimates for low volume hospitals that are close to the national 
average (i.e., to SMR = 1.0). This phenomenon is one of the principal critiques of the current CMS 
approach by some stakeholders, those who argue in favor of diﬀerent shrinkage targets for low and 
high volume hospitals, and those who argue for no shrinkage at all. Others note that use of diﬀerent 
targets appears to run counter to the CMS mandate or that in any case extreme care is needed in 
evaluating the consequences of such an approach. In section 6 the committee addresses these issues 
in detail. 
Irrespective of decisions on model augmentation, if in addition to producing hospital-speciﬁc esti­
mates the CMS reported the actual number of cases for each hospital rather than simply noting 
whether this number was < 25, users would be alerted to low information and high uncertainty. 
The committee acknowledges that in some circumstances revealing the count might lead to privacy 
problems and individual disclosures (e.g., see the discussion in Fienberg, 2011). Therefore, rather 
than recommending that the CMS report the actual number of cases, the committee notes that the 
complete reporting of statistical properties, e.g., the point estimate and conﬁdence interval, would 
communicate caution when the number of cases is low (see section 9). 
6 Volume and Other Hospital-level Attributes 
The SMR is the object of CMS inference. Some argue that if shrinking to an overall mean makes 
sense then so may shrinking towards an augmented regression model that could include volume. 
With over 4000 hospitals being evaluated, suﬃcient degrees of freedom are available to augment 
the model and still have a stable system. Appendix F describes models to accomplish the task if 
there is agreement on the conceptual base for doing so. 
Hospital volume plays an important role in hospital quality assessments because the amount of 
information to assess hospital quality depends on the number of patients treated and, with event 
data, more particularly the number of observed events. Thus, unless the analysis includes some 
form of stabilization, hospital performance estimates associated with low-volume hospitals will be 
noisy. For example, at the national level, CMS pneumonia measures have mortality rates ranging 
between 9% and 20% and readmission rates between 16% and 26%. However, for a small hospital 
the randomness associated with sample size alone can be rather large. Similarly, the median annual 
Medicare Acute Myocardial Infarction (AMI) volume in 2006 was 15 patients per hospital for the 
4171 US non-federal hospitals (Krumholz et al., 2011) studied for all-cause readmission following 
discharge for AMI. Volume varies dramatically across hospitals, however; 25% of the 4171 hospitals 
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had volumes greater than 59 and 25% had volumes less than 5. With a median volume of 15 AMI 
cases discharged alive and a national all-cause readmission rate of 18.9% for them, the probable 
error in estimating the unadjusted rate is at least ±19% (computed as for half the 
nation’s hospitals with volume less than 15 AMI patients, and is ±11% for hospitals with a volume 
of 45 AMI patients. Separation of the sampling variability (that attributed to a ﬁnite “n”) and 
case-mix eﬀects from hospital eﬀects on outcomes is both challenging and critical for isolating 
hospital quality. 
A key issue is that hospital volume and possibly other attributes are both predictors of and con­
sequences of hospital quality. Several research articles describe a volume-outcome relation, docu­
menting the “practice makes perfect” theory when examining predictors of patient mortality for 
surgical procedures (Birkmeyer et al., 2002; Dudley et al., 2000; Shahian and Normand, 2003), and 
more recently for medical admissions Ross et al. (2010). Others have shown that hospital volume 
combined with surgical mortality is a strong predictor of hospital surgical mortality (Dimick et al., 
2009). Some professional associations, such as The Leapfrog Group, have advocated the use of 
volume as a performance standard. 
Low volume hospitals present a dilemma, indeed a tri-lemma! Either highly variable estimated 
SMRs will be set aside and not reported, or they will be reported as observed (ideally with emphasis 
on their uncertainty), or the estimates will be stabilized by substantial shrinkage towards either the 
national-level typical value (an SMR = 1.0) or a shrinkage target that depends on hospital-speciﬁc 
attributes. To frame the discussion, the committee ﬁrst considered the very large information 
context. Imagine that for a given medical or surgical procedure all hospitals had a very high volume, 
suﬃciently high that the expected number of deaths was also very large. In this case the SMRs 
produced by the foregoing method, the CMS method or other such approaches would be very close 
to the direct (Observed/Expected) estimates, “what you see is what you get.” All hospital-level 
inﬂuences on outcome would take care of themselves in that the unadjusted SMR would accurately 
capture them. Indeed, the hospital eﬀects would consolidate the eﬀects of all hospital-level factors 
and in this “very large information” context would be equivalent to estimating a separate intercept 
for each hospital. 
In reality, the level of information is not very large and for some hospitals is quite small. Thus, 
the issue of using hospital-level attributes to determine the shrinkage target is driven entirely by 
the low information context. These decisions primarily aﬀect the low volume hospitals, because 
the adjustment of the estimates for high volume hospitals is relatively minor. To see this, consider 
a hospital that for a given condition has treated almost no cases. The current CMS approach will 
estimate that hospital’s SMR as very close to 1.0, irrespective of the value of the events/patients 
ratio. That is, the hospital will be reported as operating approximately at the national standard. 
Although extreme, this situation is actually quite common. The committee considered whether the 
shrinkage target should be tuned to some hospital-level attributes with the target determined by 
national-level data. 
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Arguments in favor of maintaining the current CMS approach with shrinkage of all hospital-speciﬁc 
observed rates towards an overall national mean (and thereby shrinking observed SMRs towards 1.0) 
include the concern that it could be unwise to include only one hospital-level attribute, speciﬁcally 
volume, especially when it has a partially endogenous character. 
Silber et al. (2010) provide the principal argument in favor of including volume in determining the 
shrinkage target. They showed that lower quality is associated with lower volume, and that the 
shrinkage target for stabilizing the numerator of the estimated SMR is substantially modiﬁed using 
a volume-dependent target. Furthermore, for the procedures they considered, including hospital 
characteristics in addition to volume did not substantially change the shrinkage target compared 
to using volume alone (because characteristics such as cardiac hospital, were related to hospital 
volume). This conjunction of the very attribute that produces large shrinkage also being associated 
with performance energizes the debate. 
The case for including volume is by no means “sealed” by these results and the committee notes that 
three principal points require careful consideration. First, if some low-volume hospitals perform 
well, it would be unfair to move their SMRs too far towards a single, low-volume hospital target. To 
the extent that other hospital characteristics are available to identify well-performing small facilities, 
it would be better to include both volume and other attributes, possibly with interactions, so that 
the shrinkage target is better tuned to characteristics. There are thousands of hospital-level degrees 
of freedom available and it is unlikely that more than a small fraction would be needed to capture 
most hospital-attribute-related variations in outcome. Of course, models must be procedure or 
condition speciﬁc, adding another level of complexity. 
The second principal point is that volume has a combined role as both an exogenous attribute that 
may be independently associated with quality but not “caused” by quality (e.g., practice makes 
perfect), and an endogenous attribute insofar as today’s low volume could be a consequence of 
previously observed poor quality, and therefore, in the causal pathway between the exposure (the 
hospital) and the outcome (e.g., mortality). To clarify the complexities, the committee reiterates 
that volume not be included in the model for the expected rate, or the denominator, for exactly 
these reasons. However, the issues regarding inclusion in the stabilized observed rate, or the 
numerator, is diﬀerent since the numerator is meant to represent the “best” stabilized estimate of 
the observed rate for comparison to the expected rate. Here, there are many reasonable choices for 
the shrinkage target, depending on the objectives of the evaluation. Indirectly standardized rates 
use the observed rate in the numerator; this rate is unbiased but may be too unstable for low-volume 
hospitals. By shrinking to a hospital-attribute-speciﬁc mean, hierarchical models would shrink to a 
value that best represents a small hospital’s stabilized estimate. Though there is reported research 
documenting the relation between volume and quality, the committee neither endorses nor denies 
use of volume as a component of the shrinkage target. Rather, the committee calls for careful 
study of this issue to understand the consequences of volume’s combined endogenous/exogenous 
role. There is a distinction between volume of patients for the condition studied and size of the 
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hospital as measured by the number of beds. Hospital size is ﬁxed and exogenous, and thus the 
only issue is how one should utilize size in the modeling process. 
The third argument regarding having the shrinkage target depend on volume is that “low volume” 
may well be a marker for an inadequate risk adjustment that disadvantages small hospitals. This 
failure to level the playing ﬁeld is quite possible in that though low volume hospitals contribute 
to development and estimation of the national level risk model, they are given considerably lower 
weight than are the high volume hospitals. Consequently, the “ﬁt” is generally better for the larger 
volume hospitals and the national level expected events better reﬂect the severity mix for treated 
patients. It is the case that the random eﬀects approach gives low volume hospitals relatively 
more weight than does ﬁxed eﬀects approach (another advantage of random eﬀects in the CMS 
context), but diﬀerentially inadequate risk adjustment is still possible. There may be unmeasured 
or inadequately modeled, or inadequately risk adjusted patient severity. See sections 3.5 and 4 for 
discussion of the relation between ﬁxed and random eﬀects models. 
6.1 Recommendation regarding hospital-level attributes 
The committee advises that additional evaluation is needed before deciding which hospital at­
tributes should be used in setting shrinkage targets. A strong case can be made for using hospital-
level attributes such as number of beds, both to reduce confounding when estimating the national-
level, risk adjustment model and to determine shrinkage targets for SMR stabilization. Covariate 
main eﬀects and possibly interactions need to be considered (e.g., small vs. large rural hospitals 
may have a relation diﬀerent from small vs. large urban hospitals). However, the issues associated 
with use of volume in either of these components of the assessment process are suﬃciently complex 
and contentious, that the committee recommends only that substantial evaluation is necessary. 
Similarly, CMS needs to assess the issue of possibly diﬀerentially successful risk adjustment. One 
way to conduct these evaluations is via simulation models rooted in the CMS context and with 
CMS data. The committee had neither the time nor the resources to pursue these investigations. 
Importantly, irrespective of the decision on including hospital-level covariates, the committee rec­
ommends that the data from low volume hospitals be included in national assessments. These 
data are important for determining model parameters (population mean, between-hospital resid­
ual variation, hospital-level regression parameters, etc.), and the total information so provided is 
considerable. In addition, reporting stabilized estimates even for very small hospitals avoids the 
need to determine a minimum number of cases needed before reporting an SMR. Reports need to 
be accompanied by clear explanation of the estimation process and caveats on over-interpretation. 
Finally, inclusion in the national assessment allows stakeholders to see their performance, and the 
very fact of inclusion can improve performance. 
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7 Readmission Rates 
Recent congressional legislation requires CMS to evaluate all-cause hospital readmission rates using 
an action threshold of 1.0. That is, at a speciﬁc hospital, when the ratio of the number of 30-day 
readmissions to the predicted number of such readmissions computed from national data exceeds 
1.0, the hospital is penalized. Modeling used by the CMS to create the expected readmission 
rate is similar to that for mortality outcomes although there clearly are empirical diﬀerences. See 
Krumholz et al. (2011) for details. 
The committee notes that Congress has imposed the threshold of 1.0 and that the current rules 
regarding an action threshold do not account for stochastic uncertainty in the estimated ratio. This 
lack of accounting produces unfair results for both high and low volume hospitals. For example, 
a ratio of 1.1 produced by 11/10 produces the same penalty as for the same 1.1 ratio produced 
by 110/100; a ratio of 0.9 produces no penalty (and no reward) also irrespective of the size of the 
denominator. Thus, a low-volume hospital with a true, underlying readmission rate of 1.1 is very 
likely to have an estimated rate below 1.0 incurring no penalty; a high-volume hospital with the 
same 1.1 underlying rate will be penalized most of the time. Similarly, a low-volume hospital with 
a true rate of 0.9 will frequently produce an estimate rate that exceeds 1.0; this will happen very 
seldom for a high-volume hospital. In summary, for low-volume hospitals in this situation there 
will either be high false positive rate (true rate is below 1.0) or a high false negative rate (true rate 
exceeds 1.0). The high volume hospitals are disadvantaged relative to the low because their false 
positive and false negative rates are relatively low, producing what can be relative unfairness. Of 
course if the true, underlying rate is very close to 1.0, then even high-volume hospitals will have a 
high false positive or false negative rate. 
This high volatility is a problem similar to that in estimating SMRs, but has added impact because 
ratios that exceed 1.0 generate a penalty, but ratios that are below 1.0 do not generate a reward. 
To address these issues, the committee recommends that the CMS adopt an approach to reduce 
the volatility and improve the operating characteristics of their estimator, by reducing both the 
false positive and false negative rates. Implementation would require a change in legislation, but 
making the change is very worthwhile. As developed and applied by Diggle et al. (2007); Landrum 
et al. (2000); Landrum and Normand (2003); Lin et al. (2006) and others, the substantive change 
is to replace the “ratio > 1.0” rule by one that bases the decision on a computed probability that 
the true ratio is greater than 1.0. This computation depends on the Bayesian formalism with the 
target of inference being the true, underlying observed/expected ratio. 
The approach can be based either on hierarchical, Bayes or empirical Bayes modeling similar to 
that used in computing SMRs or on frequentist Bayes (the posterior distribution is based on an 
uninformative prior and so the direct estimate is the posterior mean and the sampling variance is 
the posterior variance) In either case, with Ri the true, underlying ratio for hospital i, compute 
the posterior probability that it exceeds 1.0; PEi = pr(Ri > 1.0 | conditional on the data). This 
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probability is an informative summary of the likelihood that a hospital’s true ratio exceeds 1.0 and 
can be used to implement a penalty system. Two candidates are, 
Exceedance probability threshold: CMS (or Congress) would select a 0 < γ < 1 and identify a 
hospital as out of compliance if PEi > γ. The value of γ determines the operating character­
istic. Using γ = 0.5 is equivalent to determining whether the posterior median of R is above 
1.0. This value might be appropriate if a hierarchical, empirical Bayes approach is used, but 
would be too low if frequentist-Bayes is used. 
Pro-rata penalties: This approach would allocate penalties based on the likelihood that the 
true, underlying ratio exceeds 1.0 by applying penalties to all hospitals with the amount of 
the penalty depending on the exceedence probability, PE. Penalties could be the PE fraction 
of the full penalty; (full penalty)× PE or the PE could be partitioned, for example a PE 
≤ 0.20 produces no penalty and so on. 
The committee encourages that the CMS seriously consider these options, with speciﬁc focus on 
the fully Bayesian approach with stabilization of the observed rate (count/discharges) via shrinkage 
either to an overall national mean or to a shrinkage target that depends on hospital-level attributes. 
As for the SMR, shrinkage targets that depend on hospital-level attributes will primarily aﬀect the 
low volume hospitals, because observed rates for high volume hospitals will be relatively stable and 
adjustments will be relatively small. 
8 Model Development and Assessment 
Model development and assessment must be conducted in the context of modeling goals and con­
straints. For hospital proﬁling the case mix adjustment goal is not to ﬁnd the unrestricted best 
model for outcomes, but rather to ﬁnd the best model that does not adjust for post-admission 
patient characteristics. As discussed in section 2, section 4.3 and elsewhere, a valid and eﬀective 
model properly accounts for relevant patient-level information that is available at admission and 
associated with the outcome. Use of an eﬀective case mix adjustment model produces expected 
values that support a fair comparison, an inadequate model will treat some hospitals unfairly. The 
hospital eﬀects capture all that isn’t associated with patient attributes but are associated with the 
outcome. These, along with stochastic variation produce the deviation of an estimated SMR from 
1.0. 
8.1 The patient-level model 
Valid case mix adjustment depends on building a model that accurately predicts the probability 
of death (or readmission) using patient attributes. Thus, prediction of a binary outcome is the 
modeling goal for risk adjustment, and the full armamentarium of statistical models is available. 
The generally large number of patients supports use of rich and ﬂexible risk adjustment models 
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 produced by a combination of addition of interaction terms amongst patient-level predictors, use 
of generalized additive models or splines (Crainiceanu et al., 2007; Wood, 2006), classiﬁcation 
trees, random forests and boosting (Berk, 2008; Breiman, 2001; Hastie et al., 2009; McCaﬀrey 
et al., 2004) and similar approaches. Model comparisons and evaluations include likelihood-based 
approaches such as AIC and BIC, and for hierarchical models DIC (Bayarri and Castellanos, 2007; 
Carlin and Louis, 2009; Gelman et al., 2005; Ni et al., 2010; Spiegelhalter et al., 2002). Data-based 
assessments include residual plots, stratiﬁcation on predicted risk and computing standardized (Obs 
– Expected)/SD(Obs) (see Citro and Kalton, 2000, for examples), adjusted R2, cross-validation via 
PRESS or related approaches using a more appropriate loss function for binary outcomes (Efron, 
1978), the R2 and C statistics (Ash and Shwartz, 1999; Silber et al., 2010), the Hosmer-Lemeshow 
and AUC statistics (Spencer et al., 2008), and a variety of sensitivity analyses (Kipnis et al., 
2010). Prediction of a binary dependent variable (death/survival) is a classiﬁcation goal. Care is 
needed in comparing models and judging absolute performance because classiﬁcation performance 
as measured, for example by AUC and predictiveness (the principal goal in risk adjustment) can 
be quite diﬀerent (Pepe, 2003; Pepe et al., 2008). 
Understanding the restrictions on model development is especially important when using data-
analytic evaluations (e.g., predicted versus observed events for partitions of the data by patient-
level attributes) because the restrictions are likely to induce some large deviations. These can be 
investigated to see if enhanced patient-level modeling reduces them; if not they are likely associated 
with hospital-level attributes that are not and should not be included in the case-mix adjustment 
model. More generally, care is needed to use models that are as comprehensive and complex as is 
necessary, but no more so. 
8.2 The hospital-level model 
Assessment of the hospital level model can be undertaken using posterior predictive checks of key 
features of the between-hospital model. These may involve a comparison of the between-hospital 
observed standard deviation with that produced by posterior draws from the model. 
8.2.1 Outlying hospitals 
High-volume hospitals, especially those that are outlying from the cohort of hospitals evaluated 
can have large inﬂuence on a risk adjustment (Shahian and Normand, 2008), both with regard to 
the ﬁxed eﬀects (coeﬃcients of patient attributes) and the random eﬀect distribution. Standard 
regression diagnostics (e.g., DFFITS) and other “leave one out” approaches should accompany 
any risk adjustment. Hospitals identiﬁed to have large inﬂuence may need to have their inﬂuence 
down-weighted in developing a ﬁnal model so as to preserve their status as outliers. Alternatively, 
hospital-level, random eﬀect distributions with longer tails than a single Gaussian or with multiple 
modes also can be used to reduce the inﬂuence of outliers (see appendix H). For current approaches 
to outlier identiﬁcation in a hierarchical modeling context, see Jones and Spiegelhalter (2011). 
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8.3 Model estimation 
Due to complexity of the hierarchical model, estimation of parameters requires more eﬀort on the 
analyst’s part than when estimating a regular logistic regression model. The current CMS approach 
uses Markov chain Monte Carlo (MCMC) estimation to ﬁt the hierarchical random eﬀect parameters 
in the model, coupled with bootstrap replication to produce robust uncertainty assessments of the 
estimates. MCMC approximates the distributions of all model parameters (ﬁxed and random 
eﬀects) by sequentially sampling from conditional distributions. The approach requires use of 
good starting values to ensure model convergence (a similar requirement applies to other recursive 
methods), execution of more than one chain to assess model convergence, and designation of a lag 
with which to sample from the draws when computing distributional features of parameters (e.g., 
use every 5th draw for computing parameter estimates). 
Some authors have encountered convergence diﬃculties (e.g., see Alexandrescu et al., 2011) em­
phasizing the need for care and up-front work. Moreover, the capability of software packages to 
estimate model parameters varies; constraints such as the number of random eﬀects, the number 
of covariates, and the number of observations per hospital are examples of such features. 
Other approaches to modeling and model ﬁtting such as empirical Bayes, penalized quasi-likelihood 
(PQL: Lin, 2007) or generalized estimating equations (GEEs) are available, some more easily com­
municated than the current approach. With non-linear models, implementing the empirical Bayes 
approach requires numerical integration which is itself best done by Monte-Carlo. PQL and GEE 
may perform well for some types of conditions or procedures (e.g., those with high event rates), 
they may break down in low volume or low event-rate situations. The committee concludes that 
investigation of alternative ﬁtting methods has a low priority, but that CMS needs to improve its 
communication on the basic ideas behind their approach. This report provides guidance in this 
regard. 
9 Reporting 
Informative reporting coupled with appropriate cautions in interpretation are necessary for com­
municating complicated goals, concepts, and procedures. Furthermore, most report content must 
communicate eﬀectively to a broad range of stakeholders, including the CMS, others engaged in 
policy development and implementation, elected oﬃcials, hospital administrators, insurers, and the 
general public. These groups will have diﬀerent interests and levels of understanding. Some will 
be allowed access to information not available to others. Of course HIPAA and other disclosure 
protection requirements must be met. 
9.1 Transparency 
There is a broader issue of recommending a transparent, ongoing process of examining the conse­
quences of the many, often independent, analytic choices made; to ensure that what is done is as 
31
 

   
   
    
  
  
   
straight-forward and accessible as it can be, consistent with meeting well-articulated standards for a 
well-performing quality reporting system. CDC (2010) provides an excellent example of debrieﬁng 
on methods and provides a website for “do it yourself” computation of SIRs related to central line 
acquired infection rates (CLABSIs). 
9.2 Communicating uncertainty 
Current reporting clearly reports results using tables and graphs that communicate point estimates 
and uncertainty. Details are available on the hospitalcompare.hhs.gov website. The website 
shows how many hospitals (both nationally and within a state) were found to be better, worse or 
no diﬀerent from the national rate (and how many had too few cases to make a clear statement). 
See also, 
http://www.hospitalcompare.hhs.gov/tables/hospital-oocQualityTable.aspx?hid=

220110%2c220031 %2c22010&lat=42.3380341&lng=-71.09286029999998&stype=

MEDICAL&mcid=GRP 4& stateSearched=MA&stateSearched=MA&measureCD=

&MTorAM=MORT

and the related graphical presentations at for example, 
http://www.hospitalcompare.hhs.gov/Graphs/Hospital-OOCGraph.aspx?hid=

220110,220031,22010F&stype=MEDICAL&mCode=GRP 4&MTorAM=MORT

The committee recommends some enhancements, the most important being development and imple­
mentation of improved methods of communicating uncertainty and associated cautions. Conﬁdence 
or posterior intervals and stacked conﬁdence bands (Spencer et al., 2008; Spiegelhalter et al., 2012), 
are necessary and the experienced consumer will at least informally integrate the point estimate 
and uncertainty, but the take away message will always be the point estimates of the SMRs. If point 
estimates were better tempered by uncertainty, some (but by no means all) of the contention that 
surrounds shrinkage of hospital eﬀects toward the national mean and thereby the SMRs toward 1.0 
would be reduced. 
A new reporting format proposed by Louis and Zeger (2008) might help. The idea is to emphasize 
that an estimate is composed of the point value and its associated uncertainty by connecting them at 
the hip. For example, rather than reporting that the estimate is 0.20 with 95% conﬁdence interval 
(0.15, 0.26), the report would be that the estimate is 0.150.200.26. 
Other options include restricting reporting to conﬁdence intervals with no point estimate, or to 
comparing the conﬁdence or posterior interval for the risk-standardized death rate (or SMR) to 
the U.S. national risk-standardized rate (or to an SMR value of 1.0). If the interval estimate 
includes (overlaps with) the national value, then the hospital’s performance is, “no diﬀerent from 
the national standard.” If the entire interval estimate is below the national value, then the hospital 
is performing better than the national standard; if the entire interval estimate is above the national 
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value, then the hospital is performing worse than the national standard. Hospitals with extremely 
few cases or events in a three-year period would generate either a very broad conﬁdence interval 
or a posterior interval with the national standard far in the interior. In addition to reporting, for 
example, that the number of admission is < 25, this uncertainty helps to quantify the statement, 
“the number of cases is too small to reliably tell how the hospital is performing.” 
9.2.1 Threshold exceedance probabilities 
In addition to numerical and graphical communication of uncertainty via conﬁdence or posterior 
intervals, the committee recommends augmenting reports by (and possibly basing policy on) a 
summary other than the traditional point estimate with an uncertainty interval; speciﬁcally on 
some other features of the full SMR uncertainty distribution. Building on ideas contained in 
section 7 regarding re-admission rates, the committee proposes reporting exceedance probabilities, 
i.e., pr(SMR > s | conditional on the data) for several values of “s” or alternatively reporting the 
(5th, 25th, 50th, 75th, 95th) percentiles of the SMR. Elevating pr(SMR > 1.5 | conditional on 
the data) or some other threshold to be the primary measure of hospital performance would force 
attention on something other than the center of the distribution and would eﬀectively incorporate 
uncertainty. This approach would to some degree calm the intensity of the debate about shrinkage, 
because while the exceedance probabilities computed from the posterior distribution or from the 
frequentist Bayes approach (see section 7) are diﬀerent, the diﬀerences are smaller than for the 
point estimates. Furthermore, if a low degree of freedom t-distribution were substituted for the 
Gaussian prior distribution of the between-hospital variance component in the hierarchical model, 
diﬀerences between the Bayesian and frequentist Bayes exceedance probabilities would be further 
reduced, while retaining much of the stabilizing eﬀect of the Bayesian approach. 
9.3 Encouraging appropriate interpretations 
To emphasize that in general hospital SMRs should not be compared with one another (a caution 
that applies to all indirectly standardized rates), histograms of the patient-speciﬁc risk estimates 
for a hospital along with the national distribution or a set of other relevant comparator hospitals 
should be available to at least some stakeholders (see Shahian and Normand, 2008). 
A bivariate display may also encourage appropriate interpretations by discouraging inappropriate 
comparisons. As motivation, consider that the indirectly adjusted rate is meaningless without 
knowing the national rate for the counterfactual hospital. A number like 15% not docked or 
moored to a referent is meaningless; the counterfactual rate is needed. A SMR = 1.0 is similarly 
meaningless in the absence of the counterfactual rate. The indirect rate has no anchor; the SMR 
invites, almost forces comparison amongst hospitals. 
The committee acknowledges that perhaps no one-dimensional summary can communicate the cor­
rect messages. A two-dimensional display to consider plots the (possibly stabilized) hospital rate 
versus the national rate for the hospital’s case-mix. Points above the 45 degree line exceed the na­
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tional rate, and the horizontal dimension encourages simultaneous consideration of the comparator. 
Two hospitals on the 45 degree line are not comparable unless they superimpose or their national 
rates are very close. 
Alternatively, the (stabilized) SMRs can be plotted versus the national rate for the hospital’s case-
mix. Hospitals with points above 1.0 are in excess of their nationally computed, counterfactual 
rate, but two hospitals each with an SMR = 1.0 (or any other common value) in general will be 
associated with diﬀerent national rates, reinforcing that hospitals should not be compared. 
Data analysis principals suggest plots in the logarithmic scale, with axes labeled in the original 
scale, will be easier to read. 
These types of displays may help calm the debate regarding shrinkage targets that depend on 
hospital volume. Since it is very likely that the counterfactual, national rates for large and small 
hospitals are very diﬀerent, two such hospitals will have considerable X-axis separation. Yes, the 
low volume hospital will be shrunken more towards an SMR = 1.0 (log = 0), but such a display 
will dampen the urge to compare the two points. 
10 Best Practices 
The committee outlines best practices for a hospital proﬁling system starting with the 7 preferred 
attributes of statistical models used for publicly reported outcomes in Krumholz et al. (2006): 
1. clear and explicit deﬁnition of an appropriate patient sample, 
2. clinical coherence of model variables, 
3. suﬃciently high-quality and timely data, 
4. designation of an appropriate reference time before which covariates are derived and after 
which outcomes are measured, 
5. use of an appropriate outcome and a standardized period of outcome assessment, 
6. application of an analytical approach that takes into account the multilevel organization of 
data, 
7. disclosure of the methods used to compare outcomes, including disclosure of performance of 
risk-adjustment methodology in derivation and validation samples. 
To these the committee adds, 
8. data collection and reporting rules and data deﬁnitions that are actionable and minimize the 
opportunity for gaming, 
9. high quality control and quality assurance in data collection, data deﬁnitions, analysis and 
reporting, (not so relevant to CMS, but very relevant in other contexts), 
10. internal and external peer review of all aspects, 
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11. suﬃcient model criticism and sensitivity analyses to ensure results are sturdy with respect to 
reasonable departures from assumptions, 
12. assessments conducted in culture and operational environment of reproducible research, 
13. accurate and informative reporting, 
14. periodic re-evaluation of all components, 
15. to the degree possible consistent with HIPAA and other disclosure protections, all conducted 
in the context of reproducible research. 
10.1 Reproducible Research 
For scientiﬁc, workload and political reasons, it is important to put the proﬁling process in the 
context of reproducible research (see, Baggerly and Coombes, 2011; Mesirov, 2010) wherein there 
is an essentially seamless analytic system that starts with databases, feeds analyses that provide 
input to tables and graphs. In this context, all assumptions, data and analyses are completely 
documented and if someone wants to reproduce an analysis (possibly with some changes) they can 
do so without disturbing the integrity of the system. Eﬀective reproducibility enhances credibility 
and transparency, thereby beneﬁtting science, policy and communication. CMS provides the SAS 
code for their mortality and readmission models and thus does provide a transparent process. 
11 Findings and Recommendations 
The CMS charged the committee to, 
• 	 “Provide guidance on statistical approaches for accounting for clustering and variable sample 
sizes across hospitals when estimating hospital-speciﬁc performance metrics (e.g., mortality 
or readmission rates).” 
• 	 “Consider and discuss concerns commonly raised by stakeholders (hospitals, consumers, and 
insurers) about the use of HGLMs [Hierarchical Generalized Linear Models] in public reporting 
of hospital quality.” 
In this report, the committee has addressed issues and approaches related to the charge, and has 
identiﬁed and discussed additional issues with the goal of enhancing the validity and credibility of 
the CMS evaluations of hospital performance. 
Commentary on principal criticisms of the current CMS approach 
The committee has addressed the criticisms received by the CMS in response to the use of hierar­
chical logistic regression modeling in measure development as follows: 
Criticism 1: The approach fails to reveal provider performance variation: The hierarchical modeling 
shrinkage eﬀect reduces reported variation of hospital performance and renders the information not 
useful for consumers. 
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Committee view: The CMS seeks to report on systematic diﬀerences in patient outcome due 
to hospital quality, after removing variability in observed outcomes that is due to diﬀerences 
in case mix and stabilizing highly variable estimates. Even after risk adjustment for case-
mix diﬀerences, inherent randomness causes directly estimated hospital eﬀects and relative 
rates (that is, O/E ratios where the observed rate (O) is divided by its national model 
based expected rate (E)) for some hospitals to vary more than the systematic eﬀects that 
are to be identiﬁed. This is especially true for hospitals with extremely low volumes, whose 
ratios provide little information about their underlying relative rates due to having very 
wide conﬁdence intervals. Large reductions in reported variation are appropriate for hospital 
performance measures where the true systematic diﬀerences across all hospitals are small. 
The committee identiﬁes as a top priority evaluating the option of expanding the model to 
include shrinkage targets that depend on hospital attributes. 
Criticism 2: The approach masks performance of small hospitals: It is pointless to include small 
(low volume) hospitals in the calculations based on hierarchical modeling because they would get a 
rate close to the national mean. The hierarchical modeling methodology neutralizes small hospital 
performance. 
Committee view: Data from small hospitals provide considerable information on associations 
between patient case mix and the outcome for parameter estimation in the hierarchical model; 
therefore, their data should be included in model building. The standard errors of hospital-
speciﬁc estimates for low volume hospitals are typically large. Stabilization requires that 
these highly variable estimates are moved towards a model-based target to a greater degree 
than less variable estimates, resulting in more shrinkage for low volume hospital estimates. 
The overarching goal is to produce estimates that better reﬂect true, underlying hospital 
eﬀects. As stated in the response to criticism 1, the committee identiﬁes as a top priority 
evaluating the option of expanding the model to include shrinkage targets that depend on 
hospital attributes. 
Criticism 3: The approach is based on complicated concepts and is diﬃcult to communicate and 
explain to the public and to the providers. Stakeholders are familiar with the numerator and the 
denominator (O/E) and the output of logistic regression modeling, but the approach adopted by 
CMS replaces the “O” with a shrinkage estimate (referred to as “predicted” in CMS documents), 
and the concept is diﬃcult to convey. In addition the concept of a hospital-speciﬁc eﬀect is not 
comprehensible to most of the stakeholders. 
Committee view: Some concepts and computations are more complicated than for the stan­
dard logistic regression approach, but the additional complexity allows for respecting the 
hierarchical structure of the data and stabilizing estimates, thereby reducing regression to 
the mean eﬀects and bouncing around of provider-speciﬁc estimates. Furthermore, a ﬁxed-
eﬀects, logistic regression model also produces hospital-speciﬁc eﬀects. There is a continuum 
between the single-intercept, random eﬀects model and the ﬁxed-eﬀects model with a directly 
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estimated intercept for each hospital, with the middle ground being occupied by a mixed 
eﬀects model that includes hospital-level covariates. Therefore, barriers to comprehension of 
the concept are shared by all approaches. This report clariﬁes the principal building blocks 
of the approaches. The committee calls for improved communication on goals, methods, and 
interpretations. 
Criticism 4: The evaluation of the National Quality Forum (NQF) steering committees on use 
of hierarchical modeling has been inconsistent, contingent on the point of view of the panelists. 
Therefore, it shows a lacks of consensus among statisticians and health service researchers in using 
hierarchical modeling for risk adjustment of outcome measures. 
Committee view: The committee notes that to make progress on this issue, and possibly come 
to consensus, the debate must be evidence-based starting with a clear articulation of goals and 
ending with eﬀective evaluation of the properties of candidate approaches. The committee 
recommends use of hierarchical models as an eﬀective method to account for clustering of 
admissions within providers, to support valid and eﬀective risk adjustment, and to produce 
stabilized estimates, although it recognizes that other approaches can accomplish these goals. 
This report clariﬁes goals and why hierarchical models are a valid approach, and focuses 
discussion on potential enhancements of the current CMS method. 
The committee’s investigation has led to the following conclusions and recommendations: 
1. Use of Hierarchical Generalized Linear Models 
The committee concludes that Hierarchical Generalized Linear Logistic Modeling is an 
eﬀective analytic approach that accounts for the structure of the data used in CMS 
mortality and readmission hospital metrics. The approach accommodates modeling of 
the association between outcomes and patient-level, pre-admission characteristics; with 
appropriate inclusion of hospital-level attributes, it can adjust the patient-outcome rela­
tion for potential confounding by hospital to the degree that the necessary information 
is available; and supports stabilizing hospital-speciﬁc performance estimates by shrink­
ing direct estimates towards an appropriate target. The amount of shrinkage can be 
controlled to the extent that these controls accord with CMS’ primary goal (see Recom­
mendations 3, 4, and 5 below). 
2. Incorporation of procedure-speciﬁc volume 
Other recommendations encourage serious consideration of including hospital-level (not 
procedure-speciﬁc) attributes in the national-level, case mix adjustment model and in 
setting shrinkage targets for stabilizing estimated hospital eﬀects. The committee cau­
tions that the issues related to use of procedure-speciﬁc volume are complex. Volume 
has a combined role as both an exogenous attribute that may be an independent predic­
tor of quality (e.g., practice makes perfect) and an endogenous attribute that is in the 
causal pathway of the outcome. Furthermore, “low procedure-speciﬁc volume” may be a 
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marker for an inadequate risk adjustment that disadvantages hospitals with low-volume 
procedures. 
Though evaluation of including procedure-speciﬁc volume is important, the committee 
recommends that higher priority be given to use of other hospital-level attributes in 
modeling case-mix and in producing shrinkage targets. However, regarding volume, use 
of procedure-speciﬁc volume from time periods prior to those used in an assessment is 
likely not problematic and should be explored for its ability to contribute to better-
tailored shrinkage targets. 
3. Case-mix adjustment 
(a) Patient-level attributes 
i. Consider whether the current set of patient-level attributes should be augmented, 
for example by including race or other demographics. 
ii. Evaluate broadening modeling approaches to include additional interaction terms 
among patient-level attributes. 
iii. Evaluate further broadening patient-level models through use of splines, classiﬁ­
cation and regression trees, random forests, and boosting (see section 8) to see if 
relative to current approaches they improve case mix adjustments by producing 
predictions with lower mean squared error, or improve other performance measures 
such as those in Efron (1978). 
It will be important to explore the extent to which alternative modeling strategies im­
prove case-mix adjustments by producing predictions with lower mean squared error (i.e., 
predictions that are closer to the true structural relation), or improve other statistical 
attributes. 
(b) Hospital-level attributes 
The committee recommends that the CMS explore how best to include hospital 
attributes for two distinct purposes: 1) when developing the national-level risk 
model to reduce potential confounding induced by correlation between hospital and 
patient-level attributes; and 2) when calculating the shrinkage targets used to stabi­
lize SMRs. Incorporating them is an accepted approach in other facility assessment 
settings. It is very important to note that hospital-level attributes should not set 
the comparator for a hospital’s performance; indeed, the denominator of the SMR 
should depend only on a validly estimated relation between patient-level attributes 
and outcome. However, there may be confounding of this relationship with certain 
hospital characteristics, and methods to reduce this confounding should be explored. 
To reduce confounding and stabilize hospital-speciﬁc estimates, the committee pro­
poses in appendix F.1 a Bayesian hierarchical model that adjusts for hospital-level 
attributes when developing the risk model, but constrains risk predictions to be for 
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a “typical hospital” so that hospital-level attributes play no other role in producing 
the expected value for a hospital. The model also allows for hospital-attribute­
speciﬁc shrinkage targets to stabilize estimated SMRs. 
The committee cautions that although statistical models are available to accomplish 
these goals, decisions as to what attributes to include and how to include them must 
be carefully considered. For example, covariate interactions may be needed (e.g., 
between hospital size and rural/urban status). Coding for candidate attributes needs 
to be evaluated. For example, should size be retained as a continuous attribute or 
be categorized? If categorized, how should the number of categories, and their cutoﬀ 
values, be determined? 
4. Stabilizing estimated hospital eﬀects 
(a) Including hospital-level attributes in determining the shrinkage target when stabiliz­
ing estimated hospital eﬀects is standard practice in other facility assessment settings. 
The committee recommends that the CMS give serious consideration to including such 
variables in setting shrinkage targets. To reduce potential confounding, covariate main 
eﬀects and possibly interactions should be considered (e.g., shrinkage targets could be 
diﬀerent for each of small-rural, large-rural, small-urban, and large-urban hospitals). As 
noted in recommendation (3b), various coding choices for candidate attributes should 
be explored and evaluated. 
(b) Evaluate the policy and statistical implications of replacing the single Gaussian prior dis­
tribution for the hospital-speciﬁc random eﬀects by a more ﬂexible class of distributions 
(see appendix H). 
(c) Consider supplementing posterior mean estimates with histogram estimates. These re­
port the distribution of the SMRs with appropriate location, spread and shape (see 
appendix I). 
5. Readmission rates 
Evaluate, modify and implement the method for assessing readmission rates proposed 
in section 7. 
6. Model assessment 
Evaluate augmented approaches to model assessment (see section 8). 
7. Enhance reporting 
CMS should enhance its reporting to further emphasize uncertainty and improve inter­
pretation. The committee suggests enhancements such as: using exceedance probabili­
ties; juxtaposing a histogram of the patient-speciﬁc risk estimates for each hospital with 
a histogram of the national distribution, or of the distribution for a relevant group of 
comparator hospitals to clarify important between-hospital diﬀerences (see section 9). 
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8. Promulgate standards of conduct and communication 
(a) Develop and communicate standards of practice for data collection, analysis and report­
ing for adoption by those conducting hospital comparisons. 
(b) Implement a transparent, continuous process of examining the consequences of the many, 
often independent, analytic choices made to ensure that what is done is as straightfor­
ward and accessible as it can be, consistent with meeting well-articulated standards for 
a “well-performing” quality reporting system. 
9. Transfer technology to other CMS evaluations 
The statistical and policy issues considered in this report operate in the broad array 
of CMS performance measures and are relevant regardless of disease condition or pro­
cess measure. Therefore, CMS should broaden its evaluations to domains other than 
assessment of thirty-day, post-discharge mortality and readmission rates. However, the 
speciﬁc choices may depend on context. For example, dialysis centers may all report a 
suﬃcient number of events so that a ﬁxed-eﬀects rather than a random-eﬀects approach 
can be used in developing the national-level model and the SMRs. 
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Appendices 
A Glossary of Acronyms 
AIC: Akaiki’s information criterion 
AMI: acute myocardial infarction 
AUC: area under the curve 
BIC: Bayesian information criterion 
CABG: coronary artery bypass grafting 
CCN: [Ontario] Cardiac Care Network 
CHI: Commission for Health Improvement [UK] 
CMS: Centers for Medicare and Medicaid Services 
COPD: chronic obstructive pulmonary disease 
COPSS: Committee of Presidents of Statistical Societies 
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DFFITS: diﬀerence in ﬁts (when a case is included versus omitted from the ﬁt of the model) 
DIC: deviance information criterion 
DRG: diagnostic related group 
EDF: empirical distribution function 
GLMs: Generalized Linear Models 
HF: heart failure 
HGLMs: Hierarchical Generalized Linear Models 
HIPAA: Health Insurance Portability and Accountability Act 
HWR: Hospital-Wide Readmission 
ICC: Intra-Class Correlation 
ICU: intensive care unit 
LOS: length of stay 
MI: myocardial infarction 
MLE: maximum likelihood estimator 
NQF: National Quality Forum 
PCI: percutaneous coronary interventions 
PRESS: prediction sum of squares 
QIR: Quality Improvement Program 
RSMRs: risk-standardized mortality rates 
RSRRs: risk-standardized readmission rates 
SD: standard deviation 
SE: standard error 
SMR: Standardized Mortality Ratio 
TEP: Technical Expert Panel 
YNHHSC/ CORE: Yale New Haven Health Services Corporation/Center for Outcomes Research 
and Evaluation 
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C CMS Statement of Work and Committee Interpretation 
The Committee of Presidents of Statistical Societies, with funding from the Centers for Medicare 
and Medicaid Services (CMS), through a subcontract with YNHHSC/CORE, was guided by the 
following statement of work and subsequent committee interpretation. 
C.1 Statement of work 
The Centers for Medicare and Medicaid Services (CMS) has contracted with YNHHSC/CORE to 
develop a white paper on the appropriateness of statistical modeling for hospital outcomes measures. 
Speciﬁcally, CMS has indicated the paper should address the statistical modeling used in current 
CMS publicly reported outcomes measures for mortality and readmission (hierarchical generalized 
linear models [HGLMs]) and the concerns about this statistical approach that are frequently cited 
by stakeholders (hospitals, consumers, quality measure developers, and insurers). To develop this 
paper, YNHHSC/CORE intends to subcontract with a group of individuals recognized by profes­
sional statistical societies to provide guidance on statistical approaches for assessing hospital quality 
based on patient outcomes. Accordingly, the scope of work for this subcontract is to: 
49
 
1. Provide guidance on statistical approaches for accounting for clustering and variable sample 
sizes across hospitals when estimating hospital-speciﬁc performance metrics (e.g., mortality 
or readmission rates); 
2. Consider and discuss concerns commonly raised by stakeholders (hospitals, consumers, and 
insurers) about the use of HGLMs in public reporting of hospital quality; 
3. Develop a draft white paper regarding these ﬁndings for broad dissemination; 
4. Solicit comments from the statistical community; and 
5. Prepare a ﬁnal white paper for dissemination. 
The ﬁnal paper should be completed no later than Sept. 15, 2011. 
C.2 Committee interpretation 
The committee has reviewed the Statement of Work from CMS and provide the following interpre­
tation of it as a clariﬁcation of our plans. 
With funding from The Centers for Medicare and Medicaid Services (CMS) via a sub-contract with 
YNHHSC/CORE, a group of individuals recognized by professional statistical societies will develop 
a white paper on the appropriateness of statistical modeling for measures of hospital outcomes. The 
committee shall address the statistical modeling used in current CMS publicly reported outcomes 
measures for mortality and readmission (hierarchical generalized linear models [HGLMs]), and 
will take into account the concerns about this statistical approach as formally communicated by 
stakeholders (hospitals, consumers, quality measure developers, and insurers). The white paper 
will not consider issues related to developing appropriate case-mix adjustments and so will focus 
on use of risk-adjusted values. 
Accordingly, by September 15, 2011 the committee shall: 
1. Provide guidance on statistical approaches for accounting for clustering and variable sample 
sizes across hospitals when estimating hospital-speciﬁc performance metrics (e.g., mortality 
or readmission rates) or ranks; 
2. This guidance will take into account concerns formally communicated by stakeholders (hos­
pitals, consumers, and insurers) about the use of HGLMs in public reporting of hospital 
quality; 
3. Develop a draft white paper regarding these ﬁndings for broad dissemination; 
4. Conduct a timely and independent review of the draft document 
5. Prepare the ﬁnal report for dissemination. 
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D Background provided by the CMS 
(This information was provided by Lein Han, PhD) 
Since 2008 CMS has been publicly reporting condition-speciﬁc outcome measures such as risk ad­
justed all-cause mortality and readmission measures for AMI, HF and Pneumonia for the CMS 
Inpatient Quality Reporting (IQR) program. These measures are developed by CMS and endorsed 
by the National Quality Forum (NQF). Currently there is an increasing need for CMS to develop 
more outcome measures. Several sections of the Aﬀordable Care Act of 2010 require the Secretary 
to develop and implement outcome measures to meet a variety of program needs. Concurrent with 
the CMS’s eﬀort to expand its outcome measurement development work to meet the congressional 
mandates, CMS sought to convene a Technical Expert Panel (TEP) meeting on Statistical Model­
ing for Outcome Measures. The TEP will serve as the mechanism deployed by CMS to obtain a 
consensus on the appropriate statistical modeling methodology for outcome measure development. 
The goals of the statistical TEP meeting are to inform CMS outcome measurement development 
work. CMS expects a White Paper from the TEP that would recommend to CMS the most appro­
priate statistical modeling approach to the development of hospital-speciﬁc risk-adjusted outcome 
measures for the CMS public reporting and value-based pursing initiatives in order to (1) meet the 
congressional requirements and (2) address concerns stakeholders have expressed regarding the use 
of hierarchical logistic modeling. 
CMS uses hierarchical modeling to produce risk-adjusted hospital-speciﬁc measures for mortality, 
readmission, and complications. CMS has received some push-back from the stakeholders as well 
as research communities, such as statisticians and health service researchers, regarding use of this 
methodology. Because the TEP includes representatives from various prominent statistical societies 
in the nation, CMS expects that the statistical societies would clarify their position and provide 
guidance on the appropriate statistical modeling for risk adjusting outcome measures for public 
reporting and VBP at the provider level. Providers include hospitals, physicians, or health plan. 
The purpose is to assist in standardizing statistical modeling for outcome measure development 
across measure developers in the public and private sectors, and hence providing consistent and 
comparable information for (1) providers, (2) consumers, and (3) government to pay for perfor­
mance. 
The following describes brieﬂy the congressional mandates for outcome measure development and 
the criticisms that CMS received regarding use of hierarchical modeling. For details of the mandates, 
please review the Aﬀordable Care Act. The information intends to provide a background/context 
for the TEP’s deliberation. 
D.1 Aﬀordable Care Act 
Section 3025 establishes the Hospital Readmission Reduction Program and requires that the Sec­
retary use the CMS NQF-endorsed readmission measures for high-cost, high volume conditions to 
be selected by the Secretary. Through the FY 2012 IPPS/LTCH PPS ﬁnal rule, the Secretary 
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proposed and ﬁnalized the conditions acute myocardial infarction (AMI), heat failure (HF), and 
Pneumonia for use in the Hospital Readmission Reduction Program. section 3025 further provides, 
to the extent practicable, for the development of additional readmission measures for conditions 
identiﬁed by the Medicare Payment Advisory Commission in its June 2007 report to Congress for 
calculating the Hospital Excess Readmission Ratio as part of the basis for the hospital diagnostic 
related group (DRG) payment. 
Section 3025, and Section 399KK establish the Quality Improvement Program (QIP) It requires 
that the Secretary identify hospitals with high risk-adjusted readmission rates and make available to 
them a program to reduce readmissions and improve patient safety through the use of patient safety 
organizations. section 399KK further requires that the Secretary use the readmission measures 
selected for section 3025 to identify hospitals with high risk-adjusted readmission rates. 
In addition to the above sections, CMS plans to make use of condition-speciﬁc readmission mea­
sures to support a number of quality improvement and reporting initiatives. CMS is also in the 
process of developing a Hospital-Wide Readmission (HWR) measure that CMS may consider for 
implementation in quality programs through future rulemaking. Below are several examples of the 
criticisms received in response to the use of hierarchical logistic regression modeling in measure 
development by CMS. 
1. Fails to reveal provider performance variation: The shrinkage eﬀect of the hierarchical mod­
eling reduces the variation of the hospital performance and renders the information not useful 
for the consumers 
2. Masks the performance of small hospitals: It is pointless to include the small hospitals in the 
calculation based on hierarchical modeling because the small hospitals would get a rate close 
to the national mean. The methodology neutralizes small hospital performance. 
3. A diﬃcult concept to communicate or explain to the public and the providers: stakeholders 
are familiar with the result (the numerator and the denominator) of the logistic regression 
modeling, commonly referred to as the Observed over the Expected (O to E). Because the 
approach adopted by CMS replaces the O with a shrinkage estimate (referred to as predicted 
in CMS documents), the concept is diﬃcult to convey to the public and the stakeholders. In 
addition the concept of hospital-speciﬁc eﬀect is not comprehensible to most of the stakehold­
ers 
4. The evaluation of the NQF steering committees on the use of hierarchical modeling has been 
inconsistent contingent on the point of view of the panelists. Therefore it shows a lacks of 
consensus in using hierarchical modeling for risk adjustment for outcome measures among 
statisticians and health service researchers. 
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E The CMS Approach and Extensions 
The statistical model adopted by CMS uses variance components to characterize the potential 
sources of variation in the outcome at the patient level, after accounting for patient-level risk 
factors and hospital-level variation. To permit both types of variation, CMS uses a hierarchical 
model in which the ﬁrst stage speciﬁes a probability distribution for the risk of the outcome for 
patients treated within the same hospital. The log-odds of the event for a patient treated within a 
hospital is a function of patient-speciﬁc admission characteristics and a hospital-speciﬁc intercept. 
In the second stage, the hospital-speciﬁc intercepts arise from a normal distribution with a common 
mean and variance component. This modeling strategy is particularly useful for two reasons. First, 
it accommodates a range of plausible alternatives. If the hospital variance component is zero, then 
this implies that all diﬀerences in outcomes are explained entirely by patient-level diﬀerences in 
risk factors and sampling variability. If the between-hospital variance component is very large, 
then this implies that there are large diﬀerences in outcomes across hospitals, possibly explainable 
by other factors. However, in the absence of a model that provides at least a partial explanation, 
the hospital eﬀects are completely unrelated and so data from each hospital should be modeled 
separately. Finally, a hospital variance component between these two extremes implies moderate 
diﬀerences in outcomes across hospitals and possibly some relations among the hospital eﬀects. The 
second key reason why the modeling strategy is useful relates to the multiplicity problem. CMS is 
interested in making inferences on many parameters, e.g., on the order of 2000 to 3000 hospital-
speciﬁc ones. If the model assumptions hold, then the many-parameter problem reduces to a two 
parameter problem, involving the common mean and the between-hospital variance component. 
The CMS hospital performance measure is a risk standardized rate using the population of patients 
treated at the hospital. The performance measure uses parameters from the hierarchical model to 
determine a numerator and a denominator. The numerator reﬂects what the outcomes were at each 
hospital, but rather than using the observed number of events at the hospital, the individual risk 
probabilities for each patient in the hospital are computed by multiplying the risk coeﬃcients by 
the patients’ risk factors, adding the stabilized, hospital speciﬁc intercept, and then summing. This 
yields the (conditional) expected total number of events for that hospital. CMS uses the conditional 
expected total number of events rather than the observed number events to avoid regression to the 
mean and to gain precision for lower volume hospitals. The denominator reﬂects what the outcome 
would have been at a hospital given its actual distribution of patients but replacing the observed 
outcomes with those estimated from all hospitals in the sample. The denominator sums the individ­
ual risk probabilities for each patient within a given hospital, using the risk coeﬃcients estimated 
from the regression model, the patients’ distributions of risk factors, and the overall intercept. This 
yields the expected total number of events for that hospital. The indirectly standardized ratio, the 
numerator divided by the denominator, represents the outcome for a hospital’s speciﬁc distribution 
of patients had those patients been treated by an average provider. The ratio is converted to a rate 
by multiplying the ratio by the national percent experiencing the event. 
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E.1 Current CMS approach: Technical details 
The CMS approach involves determination of a hospital-speciﬁc estimator rather than hypothesis 
testing. Let Yij denote a binary outcome for the jth patient treated at the ith hospital, xij a vector 
of patient-speciﬁc characteristics, and ni the number of cases treated at hospital i for i = 1, 2, · · · , I 
hospitals. Assuming Yij = 1 for the jth patient treated in the i
th hospital and 0 otherwise, the 
CMS model assumes the following: 
ind
[Yij | β0i, α,xij]	 ∼ Bern(pij) where logit(pij) = β0i +αxij (2) 
iid
[β0i | µ, τ
2] ∼	 N(µ, τ2). 
and with xij denoting a vector of patient-speciﬁc admission characteristics. To increase sample 
sizes, CMS uses a 3-year observational period of data for each hospital, denoted ni. In equation 
(3) τ2 represents between-hospital variation after accounting for what the patient looked like at 
admission. Through a probability model, the CMS approach permits underlying hospital quality 
to vary around an overall mean eﬀect denoted by µ. If there are no between-hospital diﬀerences 
in the outcome beyond that captured by the xij , then τ
2 = 0 and β01 = β02 = · · · = β0I = µ. In 
this case, any observed diﬀerences in the unadjusted hospital outcomes would be due to case-mix 
(patient factors). While it is almost certain that τ2 > 0, a question is whether τ is small enough 
to ignore. 
An implicit assumption in the model deﬁned by equation (2) is that hospital mortality is indepen­
dent of the number of patients treated at the hospital, after conditioning on patient characteristics. 
The hospital-speciﬁc estimator uses as its counter-factual population subjects with the same case-
mix as those observed at the hospital, e.g., xij , and risk eﬀects quantiﬁed by the national average, 
e.g., µ and α.  ni E(Yij | β0i;xij , µ, α, τ2)j=1 ¯θ(x)i =	 × Y (3)  ni xij , µ, α, τ2)j=1 E(Yij |
= SMRi × Y¯
where  
Yij
Y¯ =
i,j 
. 
nii 
The expectation in the numerator of equation (3) integrates over the posterior distribution of β0i 
using the model in equation (2). The expectation in the denominator integrates over the prior 
distribution. In practice (µ, τ, α) are replaced by their estimated values. 
An important characteristic of the CMS hospital-speciﬁc estimator involves its comparator; each 
hospital performance is compared to a population having the same case mix as itself. This feature 
protects against extrapolation outside of the hospital’s treated case-mix; importantly, pair-wise 
comparisons of θ(x)i with θ(x)j would only be meaningful to the extent that the distributions of 
xi and xj overlap and are balanced. 
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E.1.1 Estimation 
The CMS model uses the SAS procedure PROC GLIMMIX to estimate the hierarchical model pa­
rameters and the bootstrap to calculate estimates for θ(x)i as well as 95% interval estimates (Ross 
et al., 2010). CMS makes the SAS code publicly available. 
Table 1: CMS Bootstrap Algorithm. Procedures used to estimate the CMS hospital-speciﬁc estimates 
of quality. b indexes the bootstrap sample. 
1) Sample I hospitals with replacement. 
2) Fit model in Equations (2) - (3) using all cases within each sampled hospital. Each hospital is treated 
as distinct. Using Glimmix, calculate 
(a) The hospital ﬁxed eﬀects: αˆb . 
(b) The parameters governing the hospital-speciﬁc random eﬀects distribution, µˆb, and τˆ2(b). 
(c) The set of hospital-speciﬁc estimates andh corresponding variances, {βˆ0i, var(β0i); 
i = 1, 2, · · · , I}. If a hospital is sampled more than once, randomly select one set of hospital-speciﬁc 
estimates and hyper-parameters. 
3) Simulate a hospital random eﬀect by sampling from the posterior distribution of the 
hospital-speciﬁc distribution obtained in Step 2(c). The posterior is approximated by a normal 
distribution, βˆb∗0i ∼ N(βˆ0i, var(β0i)) for the unique set of hospitals obtained from 
Step 1. 
4) Within each unique hospital i sampled in Step 1, and for each observation j in that hospital, 
calculate θˆ(x)
(b)
i using αˆ
b(k) from Step 2 and using βˆb∗0i from Step 3, 
θˆb(x)i = log 
Pni
j=1 logit
−1
(βˆ
b∗(x)
0i +αˆ
b(x)xij)
Pni
j=1 logit
−1
(µˆb(x)+αˆb(x)xij) 
+ log( Y¯ ) and 
for i = 1, 2, · · · , I. Logarithms are taken to ensure positivity of the estimates. 
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F Modeling to Allow for Hospital-Attribute Shrinkage Targets 
In order to allow hospital-level attributes to inﬂuence the shrinkage targets for stabilization of 
the SMR in the numerator model, there must be some de-linkage of the risk adjustment and the 
stabilization components. The following two approaches are strategically diﬀerent. Both require 
careful implementation and comparison to the current model when there are no hospital-level 
covariates included. Comparisons should be empirical, involving the same datasets, and property-
based, involving simulations. 
F.1 A generalization of the current CMS model 
The committee recommends that hospital-level attributes be used in developing the national-level 
risk model to reduce potential confounding induced by correlation between hospital and patient-
level attributes, and that they also be used to develop shrinkage targets when stabilizing SMRs. 
Regarding the former role, it is absolutely the case that hospital-level attributes should not set the 
comparator for a hospital’s performance; that should depend only on a validly estimated relation 
between patient-level attributes and outcome. However, there may well be confounding of this 
relation by hospital, and it is important to have a way to reduce this confounding. 
To address the confounding reduction and stabilization goals, the committee proposes the following 
Bayesian hierarchical model that adjusts for hospital-level attributes when developing the risk 
model, but risk predictions for individual patients to estimate the expected rates are constrained to 
be for a “typical” hospital. Hospital-level attributes play no other role in producing the expected 
value for a hospital. The model also allows for hospital-attribute speciﬁc shrinkage targets to 
stabilize estimated SMRs. The committee cautions that though statistical models are available to 
accomplish these goals, the decision on what attributes to include needs to be carefully considered. 
These issues are discussed in other sections of this report. 
The following development follows directly from that for the current CMS model in appendix E.1. 
Let Yij = 1 for the jth patient treated in the i
th hospital and 0 otherwise. Assume the following, 
ind 
[Yij | β0i, α,xij]		 ∼ Bern(pij) where logit(pij) = β0i + αxij (4) 
iid
[β0i | µ, τ
2, γ, zi] ∼ N(µ+ γzi, τ
2), 
with xij denoting a vector of patient-speciﬁc, admission characteristics and zi denoting a vector of 
hospital-level attributes that are to be used to develop shrinkage targets for the numerator of the 
SMR. Note that, though the zi do appear in the prior distribution for the β0i, as clariﬁed below 
they are not used to adjust the reference population when computing an SMR. 
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The proposed, hospital-speciﬁc estimator is,
 
ni
j=1E(Yij | β0i;xij, zi, µ, τ
2, α, γ) 
¯θ(x)i = ni × Y , (5) xij , z ∗, µ, α, τ2, γ)j=1E(Yij | 
= SMRi × Y¯
where 
i,j Yij
Y¯ = 
nii 
∗and z is chosen to satisfy 
I ni 
Y¯ 
 =

L L 
E(Yij | xij , z 
∗, µ, α, τ2, γ). (6)
 
i=1 j=1
The expectation in the numerator of equation (5) integrates over the posterior distribution of 
β0i using the model in equation (4). The expectation in the denominator of equation (5) and 
in equation (6) integrates over the prior distribution with a ﬁxed set of hospital-level attributes; 
∗ ∗zi ≡ z If z has more than one component, the there will be a variety of z that satisfy equation (6), 
but they will all produce the same predicted number of events for a hospital. In practice (µ, τ, α, γ) 
are replaced by their estimated values. A simple adaptation of the methods used for the current 
CMS model should work for this expanded model. 
The current CMS model corresponds to the exclusion of hospital-level covariates. While hospital-
level attributes enter into the prior for the β0i, they do not change the referent population. An 
SMR = 1.0 is still interpreted as the hospital is performing at the nationally predicted level for 
a counterfactual hospital with the same case-mix. Inclusion of the zi increases the degree of 
adjustment for hospital confounding over that provided by the random eﬀects speciﬁcation for the 
β0i and so the estimated values for (µ, τ
2, α) will be diﬀerent from those for the current model, 
but the estimation goal remains unchanged. Inclusion of the hospital-level attributes in the risk 
model will produce an estimated τ2 that is smaller than that produced by the current CMS model. 
Thus, the weight on the direct estimate will be smaller, but the shrinkage will be towards the target 
determined by hospital-level attributes rather than to an overall, hospital-independent value. 
F.2 A two-stage approach 
The following, two-stage approach is included for illustrative purposes. It clariﬁes the separate roles 
of the risk prediction as stabilization components of the assessment process. The ﬁrst stage extracts 
ˆestimated hospital eﬀects (denoted by β0i) and their standard errors. These are then analyzed by 
a random eﬀects model.1
1Before statistical theory and computing to estimate uniﬁed models were available, this approach was in common use, 
sometimes referred to as “the NIH model.” 
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F.2.1 The stage 1, direct SMR model 
Assume that the CMS national-level hierarchical logistic regression (see appendix E.1) is available to 
produce the national-level expected deaths. Speciﬁcally, denote the denominator of equation (3) by 
EDi(xij, µ, α, τ
2) and using the observed number of hospital-speciﬁc deaths (Yi+) as the numerator 
produce the directly estimated SMR (denoted dSMR), 
Yi+
dSMRi = , i = 1, . . . , I. (7) 
EDi(xij , µ, α, τ2) 
ˆTo estimate the hospital eﬀect, ﬁnd the value of µ in equation (7) (denoted by β0i ) so that, 
EDi(xij , βˆ0i, α, τ
2) = Yi+ . 
So, we have the relations, 
Yi+ EDi(xij , βˆ0i, α, τ
2)
dSMRi = = . (8) 
EDi(xi, µ, α) EDi(xij , µ, α, τ2) 
ˆThe (β0i − µ) are hospital eﬀects (in fact, estimated hospital ﬁxed eﬀects). They consolidate over 
the patient mix all hospital inﬂuences that operate after having adjusted for case mix. Their values 
ˆ ˆdirectly translate into dSMR values; for example if β0i = µ, then dSMRi = 1.0, if β0i < µ, then 
dSMRi < 1.0, etc. With I > 1800, there are a large number of them; some quite stably estimated, 
others quite unstable. 
ˆTo compute the full sampling distribution for the β0i one could use a simulation that repeatedly 
generates Y+i from the national-level risk model (details omitted), and then use it to estimate the 
ˆthe standard errors of the β0i (denoted by σi) and conﬁdence intervals for them and thereby for the 
ˆ ˆdSMRs. For example, a 95% interval corresponds to replacing β0i in equation (8) by β0i±1.96× σˆi. 
F.2.2 The stage 2, (empirical) Bayes model 
As in appendix F.1, let zi be a vector of hospital-level attributes. Using the normal-distribution 
model (see appendix H for other models) write, 
[β0i | µ, τ
2, γ, zi] ∼ N(µ+ γzi, τ
2) (9) 
[βˆ0i | β0i, σ
2] ∼ N(β0i, σ
2)i i 
In the empirical Bayes approach all hospitals contribute information for estimating the prior mean, 
ˆvariance and regression slopes (the γ). Speciﬁcally, the collection of (β0i, σˆi) are used to produce 
(µˆ, τˆ2 ,ˆ γ). The estimated prior variance (τˆ2) quantiﬁes the amount of variation in the βˆ0i that is 
not explained by the σˆ2 or the γzi. Recursive estimation is needed (See Carlin and Louis, 2009, for i 
ˆdetails). Though more weight is given to the low variance β0i than to the highly variable ones, the 
weights are ﬂatter than those produced by 1/σˆ2 and even low volume (large σˆ2) hospitals contribute i i 
substantially to these estimates. 
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The “plug-in” posterior means are the shrunken estimates, 
βpm 
τˆ2ˆ 
0i = E(β0i | βˆ0i, σˆi 
2, µ, ˆ2 γ, zi) (µˆ+ ˆ {ˆ ˆ+ ˆˆ τ , ˆ = γzi) + β0i − (µ γzi)}
τˆ2 + σˆ
i
2
and the plug-in posterior variances are, 
τˆ2ˆ σ2 τ2 σ2V (β0i | β0i, ˆ µ, ˆ , γ,ˆ zi) = .i , ˆ ˆiτˆ2 + σˆ2i 
The amount of shrinkage depends on the relation between σˆ2 and τˆ2. Highly variable direct i 
estimates are given less weight with more allocated to the hospital-attribute speciﬁc shrinkage 
target (µˆ + γˆzi). Because τˆ
2 measures unexplained variation at the hospital level around the 
hospital-attribute speciﬁc mean, hierarchical models allow for between-hospital variation, but do 
βpm not require that it exists. For example, if τˆ2 were forced to equal 0, ˆ ≡ (µˆ + γˆzi); if τˆ
2 were 0i 
βpm 
.
σ2 ˆ ˆforced to be, say, 1000 times larger than the largest ˆi , = β0i. This latter relation with 0i 
the posterior mean equal to the direct estimate and the posterior variance equal to the sampling 
variance produces the directly estimated SMRs (the dSMRs) and has been termed “frequentist 
Bayes.” It is proposed as a reporting option in sections 7 and 9. 
If no hospital-level attributes are included in the prior (γ ≡ 0), then the estimates for hospitals 
with large σˆ2 are moved close to the national mean (µˆ), producing estimated SMRs close to 1.0. i 
This feature generates a principal point of debate regarding whether and how to use hierarchical 
models with associated shrinkage. 
G The Michigan, Canadian and United Kingdom Approaches 
The subsequent subsections outline the Michigan, Canadian and United Kingdom approaches to 
hospital proﬁling. 
G.1 The Michigan Approach 
Since 1995, the University of Michigan’s Kidney Epidemiology and Cost Center has produced dial­
ysis facility-speciﬁc information (www.dialysisreports.org) for CMS. CMS displays this information 
on their Dialysis Facility Compare website, similar to their Hospital Compare website. In addi­
tion to process measures, each facility’s actual patient survival is compared to its expected patient 
survival. Data from each facility cover a three-year observation window. Covariates in this model 
include a patient’s age, race, sex, diabetes, and years on dialysis, whether they had other health 
problems when they started dialysis, additional diagnoses such as cancer or heart problems and 
body size. Facilities’ survival rates are categorized as better than expected, expected, or worse 
than expected. 
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G.2 The Canadian Approach 
Canadian public hospital reporting is limited to coronary artery bypass graft (CABG). The Ontario 
Cardiac Care Network (CCN) produces hospital-speciﬁc estimates of outcomes including in-hospital 
and 30-day mortality, and complications, such as hospital length of stay (LOS), ICU LOS and blood 
transfusion. The models used to create the risk-adjusted hospital-speciﬁc estimates are standard 
logistic or Poisson regression, adjusting for relevant patient risk factors obtained from clinical chart 
data, with no inclusion of hospital random eﬀects or adjustment for clustering of patients within 
hospitals. From these models, CCN produces expected numbers of events at each hospital and 
computes indirectly standardized rates as observed divided by expected rates. The estimates are 
disseminated to the 14 CABG hospitals and published in a report on the CCN website that requires 
a member password to view the information (http://www.ccn.on.ca/index.php). See Spencer et al. 
(2008) for additional details. 
G.3 The UK Approach 
(Based on comments of an external reviewer) 
Methods used by the Care Quality Commission (CQC) are based on using data to target regulatory 
activity, i.e. giving data to inspectors to guide them in their work such that regulatory activity is 
targeted. In generating data to do this, a variety of techniques are used, including generating risk 
estimates that are displayed as a series of dials in the “Quality and Risk Proﬁle” (QRP). See, 
http://www.cqc.org.uk/guidanceforprofessionals/nhstrusts/

ourmonitoringofcompliance/qualityandriskprofiles.cfm

These are used by inspectors and can be used to initiate surveillance techniques. These use time 
series data and other statistical methods to generate ﬁndings where there are higher than expected 
death rates (known as the outliers program). See, 
http://intranet.cqc.local/CQCIntranet/news--events/news--updates/

2010/cqc%e2%80%99s-outliers-programme.aspx

In addition, the Intelligence Directorate at the CQC employs a range of other techniques and 
products that use data to guide regulatory activity. These include thematic reviews and a program 
of National Health Service surveys. In some cases information is used to very quickly trigger activity 
with a provider (e.g., information received from a whistleblower), while in other cases a statistical 
model is used to consolidate a large number of data sources using diﬀerent utilities and weights 
(the QRP approach). 
H Flexible Prior Distributions and Histogram Estimates 
Moving away from a single, Gaussian prior distribution for the random eﬀect in a hierarchical logistic 
regression has the potential to absorb some of the controversy associated with over-shrinkage, 
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wherein either outliers are masked or high variance (low volume) hospitals are shrunken close to 
the national value. In addition, using model output to compute SMR estimates with a distribution 
that better reHects the distribution of the true, underlying SMRs should be considered. For each 
shrinkage can be less than with the normal without the need to include hospital-level attributes. 
H.t Low degree of freedom t -distribution prior 
Use of a low degree of freedom (df), t-distribution prior will avoid over-shrinking truly outlying 
hospital effects. However, its use will only minimally affect shrinkage for low volume (high variance) 
hospitals because the degree of shrinkage control depends on the Z-score (estimate/SE ) of the MLE 
estimated hospital effect from a logistic regression. Figure 1 displays the relation among the df, 
observed data and posterior mean and highlights this Z-score dependence. 
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Figu re 1: Posterior mean a function of the observed data (Z = M LE/a = MLE/ 5E) for various degrees 
of freedom. T he priors are sca led to have T2 = 1 and for this exa mple the conditional varia nce (72 = 1. 
So, for the norma l prior (df = 00) the weight on the data is 0.50. The MLE (450 line) is also included. 
Note that for 5 df , when the MLE is less than 2·SE from the population value (0 in our example) , 
the posterior mean is virtually identical to that for the normal prior. Beyond that, the t-prior 
shrinks less and as Z increases the posterior mean is approximately a fixed translation of the 
MLE. This shrinkage control will maintain identification of outliers (large IZ I), but will still impose 
considerable shrinkage towards the population mean on average for at least 95% of the MLEs 
(those less than 2 times their sampling standard deviation from the population mean). Thus, much 
of the stabilization conferred by the normal p rior will be retained. Importantly, in addition to 
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maintaining more weight on the highly deviant MLEs than does the normal prior, the posterior 
variance associated with a low degree of freedom t-prior will correspondingly increase with the 
deviation of the MLE from the population mean. 
H.2 Mixture of normal or t distributions 
As Magder and Zeger (1996) show, a mixture of distributions is an eﬀective way to broaden the 
family of prior distributions. Relative to a single normal with 2 degrees of freedom (mean and 
variance), the three-component mixture requires 8 df (2 df for each normal plus 2 df for the mixing 
weights {the three weights must add to 1.0}), 6 df more than for the single normal. Generally, 
components of latent mixtures can be poorly identiﬁed, but the estimated overall shape will be 
very stable. 
The strategic computations would be identical to the current approach, but the form of the prior 
would be diﬀerent (e.g., multi-modal). So, shrinkage would be more complicated than with the 
single normal, but still there would be a posterior mean. The posterior mean would be a weighted 
average of the three posterior means associated with the three normal components; the weights 
would be proportional to the prior odds times the marginal likelihood ratio with marginal likelihoods 
computed from the normals. With a modest increase in computational overhead, the normal 
components of the mixture can be replaced by t-distributions. 
Though attractive in principle, the mixture approach will have little eﬀect on the estimates for 
hospitals with a small number of events because for these hospitals the likelihood ratio of the two 
marginal distributions will be very close to 1.0 and the shrinkage target will be close to the national 
mean (the a priori weighted average of the component-speciﬁc means). 
H.3 Semi-parametric priors 
Paddock et al. (2006); Paddock and Louis (2011) evaluate performance of Dirichlet process priors 
in estimating the underlying prior (they don’t provide information on consequent performance in 
estimating parameters such as RSMRs). With the large number of hospitals being evaluated by 
CMS, suﬃcient data are available to support this approach (for an example, see Lin et al., 2009), 
but to ease communication, maintain credibility, and likely add suﬃcient ﬂexibility, use of either a 
single t-distribution or a mixture of three normal distributions is likely suﬃcient. 
H.4 Use of a prior distribution other than Gaussian 
The possibility of replacing the normal distribution provides another entry point to the issue of 
possible over-shrinkage in the context of assessing hospital quality of care. The prior distribution 
for the hospital random eﬀects describes the plausible range, mean, mode, and other features of 
these eﬀects, after adjusting away patient risk factors. Is it sensible to move away from a symmetric, 
unimodal prior or should it be at least approximately symmetric so that some intercepts are high 
and some intercepts are low with the median and the mode either identical or very close? In the 
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context of a symmetric, unimodal prior, does the use of low degree of freedom t-distributions with 
longer tails provide insuﬃcient stabilization for too many hospitals? What does use of a multi-
modal prior imply about computation of risk-standardized mortality rates? These questions relate 
to the underlying arrangement of true hospital eﬀects and to policy goals. Therefore, discussion 
and evaluation of these and other options address policy issues, of course as manifested in statistical 
considerations. 
Histogram estimation 
The empirical distribution function (edf) or histogram of estimates based on posterior means of 
target parameters is under-dispersed relative to that for the true-underlying values and the edf of the 
direct (MLE) estimates is over-dispersed. Shen and Louis (1998) proposed triple-goal estimates that 
optimally estimate the edf, produce optimal ranks and lose very little of the estimation advantages 
conferred by posterior means. Lin et al. (2006, 2009) generalized the approach and applied it 
to evaluating dialysis center SMRs using the United States Renal Data System database. These 
estimates are more spread out than the posterior means and should be considered as an alternative 
to using posterior means. They have the added beneﬁt of compatible results for all monotone 
transforms of the target parameter. For example, the same estimated SMRs are produced by direct 
analysis of them or analysis of the log(SMRs) followed by exponentiation. 
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